<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Res Bull</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Res. Bull</journal-id>
<journal-title-group>
<journal-title>Brain Research Bulletin</journal-title>
</journal-title-group>
<issn pub-type="ppub">0361-9230</issn>
<issn pub-type="epub">1873-2747</issn>
<publisher>
<publisher-name>Elsevier Science</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28212850</article-id>
<article-id pub-id-type="pmc">5766741</article-id>
<article-id pub-id-type="publisher-id">S0361-9230(17)30082-5</article-id>
<article-id pub-id-type="doi">10.1016/j.brainresbull.2017.02.001</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human astrocytes in the diseased brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dossi</surname>
<given-names>Elena</given-names>
</name>
<email>elena.dossi@college-de-france.fr</email>
<xref ref-type="fn" rid="fn0005">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasile</surname>
<given-names>Flora</given-names>
</name>
<email>flora.vasile@college-de-france.fr</email>
<xref ref-type="fn" rid="fn0005">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rouach</surname>
<given-names>Nathalie</given-names>
</name>
<email>nathalie.rouach@college-de-france.fr</email>
<xref ref-type="corresp" rid="cor0005">⁎</xref>
</contrib>
</contrib-group>
<aff id="aff0005">Neuroglial Interactions in Cerebral Physiopathology, Center for Interdisciplinary Research in Biology, Collège de France, CNRS UMR 7241, INSERM U1050, Labex Memolife, PSL Research University, Paris, France</aff>
<author-notes>
<corresp id="cor0005"><label>⁎</label>Corresponding author. <email>nathalie.rouach@college-de-france.fr</email></corresp>
<fn id="fn0005">
<label>1</label>
<p id="npar0005">E.D. and F.V. equally contributed to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>1</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<volume>136</volume>
<fpage>139</fpage>
<lpage>156</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>8</day>
<month>2</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Authors</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract abstract-type="author-highlights" id="abs0005">
<title>Highlights</title>
<p>
<list list-type="simple">
<list-item id="lsti0005">
<label>•</label>
<p id="par0005">Astrocytes are active dynamic signalling players of the brain.</p>
</list-item>
<list-item id="lsti0010">
<label>•</label>
<p id="par0010">Dysfunctions of astrocytes can contribute to the pathogenesis of brain disorders.</p>
</list-item>
<list-item id="lsti0015">
<label>•</label>
<p id="par0015">A common pathological hallmark of several CNS diseases is reactive astrogliosis.</p>
</list-item>
<list-item id="lsti0020">
<label>•</label>
<p id="par0020">Targeting astrocytes represent an alternative approach to develop new therapies.</p>
</list-item>
</list>
</p>
</abstract>
<abstract id="abs0010">
<p>Astrocytes are key active elements of the brain that contribute to information processing. They not only provide neurons with metabolic and structural support, but also regulate neurogenesis and brain wiring. Furthermore, astrocytes modulate synaptic activity and plasticity in part by controlling the extracellular space volume, as well as ion and neurotransmitter homeostasis. These findings, together with the discovery that human astrocytes display contrasting characteristics with their rodent counterparts, point to a role for astrocytes in higher cognitive functions. Dysfunction of astrocytes can thereby induce major alterations in neuronal functions, contributing to the pathogenesis of several brain disorders. In this review we summarize the current knowledge on the structural and functional alterations occurring in astrocytes from the human brain in pathological conditions such as epilepsy, primary tumours, Alzheimer’s disease, major depressive disorder and Down syndrome. Compelling evidence thus shows that dysregulations of astrocyte functions and interplay with neurons contribute to the development and progression of various neurological diseases. Targeting astrocytes is thus a promising alternative approach that could contribute to the development of novel and effective therapies to treat brain disorders.</p>
</abstract>
<kwd-group id="kwd0005">
<title>Abbreviations</title>
<kwd>Aβ, amyloid Beta</kwd>
<kwd>AQP, aquaporin</kwd>
<kwd>AD, Alzheimer’s disease</kwd>
<kwd>CNS, central nervous system</kwd>
<kwd>Cx, connexin</kwd>
<kwd>DS, Down syndrome</kwd>
<kwd>GJ, gap junction</kwd>
<kwd>GFAP, glial fibrillary acidic protein</kwd>
<kwd>GS, glutamine synthetase</kwd>
<kwd>HS, hippocampal sclerosis</kwd>
<kwd>IP3R2, inositol triphosphate receptor 2</kwd>
<kwd>MDD, major depressive disorder</kwd>
<kwd>MTLE, mesial temporal lobe epilepsy</kwd>
<kwd>mGluR5, metabotropic glutamate receptor 5</kwd>
</kwd-group>
<kwd-group id="kwd0010">
<title>Keywords</title>
<kwd>Astrocytes</kwd>
<kwd>Humans</kwd>
<kwd>Brain</kwd>
<kwd>Pathology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec0005">
<label>1</label>
<title>Introduction</title>
<p id="par0025">Astrocytes are active dynamic signalling players of the central nervous system (CNS). Over the past 25 years it has become clear that astrocytes participate to a variety of essential physiological processes in the healthy brain. Indeed, far from being merely passive cells providing structural support to neurons, astrocytes are now viewed as crucial active and dynamic elements of the brain circuitry: they participate in formation and maturation of synapses, receptor trafficking, control of the homeostasis of ions and energy metabolites and clearance of neurotransmitters. They also regulate the extracellular space volume and modulate the moment-to-moment synaptic plasticity (<xref ref-type="bibr" rid="bib0035">Araque et al., 2014</xref>, <xref ref-type="bibr" rid="bib0250">Dallérac and Rouach, 2016</xref>). Many studies have shown their contribution to information processing and memory formation in the brain, thereby pointing to a role of astrocytes in higher integrated brain functions. Dynamic bidirectional signalling between astrocytes and neurons has mainly been reported in experimental animal models. Recent data however show that such reciprocal signalling also occurs in the human brain. Astrocytes from human brain tissue indeed exhibit Ca<sup>2+</sup>-based “intrinsic excitability” and can respond to synaptically-released neurotransmitters (<xref ref-type="bibr" rid="bib0770">Navarrete et al., 2012</xref>). Furthermore, morphological, genomic and functional studies have revealed that human astrocytes display specific characteristics compared to the rodent counterpart (<xref ref-type="bibr" rid="bib0715">Miller et al., 2010</xref>, <xref ref-type="bibr" rid="bib0785">Oberheim et al., 2006</xref>, <xref ref-type="bibr" rid="bib0790">Oberheim et al., 2009</xref>, <xref ref-type="bibr" rid="bib1270">Zhang et al., 2016</xref>, <xref ref-type="bibr" rid="bib1275">Zheng et al., 2015</xref>). Human astrocytes display a remarkable morphological diversity according to cortical layers, being larger and more complex than those of rodents; furthermore, they exhibit a high expression of proteins involved in Ca<sup>2+</sup> signalling and propagate Ca<sup>2+</sup> waves at much faster velocities than their rodent counterparts (<xref ref-type="bibr" rid="bib0050">Bazargani and Attwell, 2016</xref>, <xref ref-type="bibr" rid="bib0790">Oberheim et al., 2009</xref>). Altogether, these findings support the idea that in the human brain, astrocytes may play a crucial role underlying higher cognitive functions. Alterations in astrocyte physiological roles have thus been hypothesized to contribute to cerebral pathology. Indeed, as early as in the 19<sup>th</sup> century, several neuropathologists such as Alzheimer, Fromman and Nissl, already envisioned a role for glia in brain diseases. Nonetheless, since the beginning of the 20<sup>th</sup> century the concept that neurological diseases result primarily from neuronal dysfunction dominated. However, this neurocentric paradigm did not systematically lead to prominent advances in therapies for brain diseases. Such diseases indeed still remain the most complicated to understand and treat. Growing evidence from analysis of post-mortem or surgically resected human tissues and from animal models of CNS pathologies indicate that astroglial dysfunctions contribute to the pathogenesis of several neurological and psychiatric disorders (<xref ref-type="bibr" rid="bib0415">Halassa et al., 2007</xref>, <xref ref-type="bibr" rid="bib0950">Rossi and Volterra, 2009</xref>).</p>
<p id="par0030">In this review we focus on human-specific astroglial changes in some frequent neurological disorders, such as epilepsy, brain tumours, Alzheimer’s disease, major depressive disorder and Down syndrome.</p>
</sec>
<sec id="sec0010">
<label>2</label>
<title>Astrogliosis as a hallmark of brain diseases</title>
<p id="par0035">A common feature and pathological hallmark of several CNS diseases is reactive astrogliosis (<xref ref-type="fig" rid="fig0005">Fig. 1</xref>). It consists of a finely graded continuum of molecular, cellular and functional changes in astrocytes in response to CNS injuries; these alterations vary according to the severity of the disease (<xref ref-type="bibr" rid="bib0030">Anderson et al., 2014</xref>, <xref ref-type="bibr" rid="bib0290">Eddleston and Mucke, 1993</xref>) and are regulated through inter- and intracellular signalling molecules in a context-specific manner (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>). In mild or moderate astrogliosis, which is generally associated with mild trauma or located in areas at a certain distance from CNS lesions, astrocytic proliferation is almost absent. Variable increased glial fibrillary acidic protein (GFAP) expression has also been observed, together with cell body and process hypertrophy, which is not altering astrocyte organization into individual distinct domains (<xref ref-type="bibr" rid="bib1205">Wilhelmsson et al., 2006</xref>). Furthermore, other proteins are up-regulated in reactive astrocytes, such as copper-zinc superoxide dismutase, glutathione peroxidase or metallothionein. Moderate astrogliosis also results in expression of inducible nitric oxide synthase and release of trophic factors and cytokines, including tumour necrosis factors α and β, interleukins and interferons (<xref ref-type="bibr" rid="bib0175">Chen and Swanson, 2003</xref>). In mild or moderate forms, reactive astrogliosis exhibits the potential for resolution, if the initial triggering insult resolves or is removed; in this case, cells return to a condition similar to that observed in healthy tissue (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>). On the contrary, near focal lesions, infections or neurodegenerative areas severe diffuse astrogliosis is characterized by enhanced astrocytic proliferation. Molecular factors promoting proliferation of reactive astrocytes are not completely characterized, but a role for epidermal growth factor, fibroblast growth factor, endothelin 1, ATP, lipopolysaccharide and nitric oxide has been identified (<xref ref-type="bibr" rid="bib0355">Gadea et al., 2008</xref>, <xref ref-type="bibr" rid="bib0625">Levison et al., 2000</xref>, <xref ref-type="bibr" rid="bib0775">Neary and Zimmermann, 2009</xref>, <xref ref-type="bibr" rid="bib1075">Sofroniew and Vinters, 2010</xref>). This enhanced astrocytic proliferation causes intermingling and overlapping of neighbouring astrocytic processes, which disrupts individual astrocyte domains. In some cases, this potent astrocytic reaction can drive the formation of a compact glial scar (<xref ref-type="fig" rid="fig0005">Fig. 1</xref>). Such scar is characterized by astrocyte interaction with different cell types and is mainly formed along the borders of severe tissue damage, necrosis, tumours, chronic neurodegeneration, infection or inflammatory infiltration (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>, <xref ref-type="bibr" rid="bib1075">Sofroniew and Vinters, 2010</xref>). These structural changes are long-lasting and persist after the resolution of the triggering insult (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>). Moreover, mature glial scars act as barriers to inflammatory cells to protect surrounding healthy tissue from nearby areas of intense inflammation. Reactive astrocytes can also protect CNS cells and tissue by uptaking excitotoxic glutamate, producing glutathione against oxidative stress, degrading amyloid β peptides, regulating extracellular space volume and ion balance, facilitating blood brain barrier repair and regulating CNS inflammation. Nevertheless, growing evidence also shows that reactive astrocytes can contribute to or be the primary source of CNS physiopathology. Reactive astrocytes from glial scars can indeed synthesize collagen and sulphate proteoglycans, which prevent axon regeneration (<xref ref-type="bibr" rid="bib0175">Chen and Swanson, 2003</xref>). In addition, alteration of the physiological functions of astrocytes resulting from genetic mutations contribute to brain disorders such as Alexander’s disease and amyotrophic lateral sclerosis (<xref ref-type="bibr" rid="bib0120">Brenner et al., 2001</xref>, <xref ref-type="bibr" rid="bib0740">Nagai et al., 2007</xref>). These opposite effects of reactive astrocytes thus point to a dual function of astrogliosis (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>, <xref ref-type="bibr" rid="bib1075">Sofroniew and Vinters, 2010</xref>).<fig id="fig0005"><label>Fig. 1</label><caption><p><bold>Astrogliosis in pathological human brain</bold>. Top, schematic representation of different gradation of astrogliosis depending on the gravity of the insult. Bottom, astrocyte morphology in normal tissue from a human autopsy specimen far from a lesion (left), and in presence of moderate (middle) and severe diffuse reactive astrogliosis (right). For each condition, a brightfield immunochemistry for GFAP counterstained with haematoxylin is shown on the left, and an enlarged view of the boxed areas on the right. Scale bars: left, 50 μm; right, 20 μm. [upper part modified from (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>); bottom part from (<xref ref-type="bibr" rid="bib1075">Sofroniew and Vinters, 2010</xref>)].</p></caption><alt-text id="at0485">Fig. 1</alt-text><graphic xlink:href="gr1"></graphic></fig></p>
</sec>
<sec id="sec0015">
<label>3</label>
<title>Epilepsy</title>
<p id="par0040">Epilepsy is one of the most prevalent neurological diseases affecting 1% of the world population (World Health Organisation, 2016, <ext-link ext-link-type="uri" id="intr0005" xlink:href="http://www.who.int/en/">http://www.who.int/en/</ext-link>). It is characterized by repetitively recurrent seizures, which disrupt normal brain functions and can damage the brain and worsen pre-existing neurological deficits. Contrary to the traditional view assuming that epileptic activity is generated exclusively in and by neurons, an astrocytic basis for epilepsy has been proposed (<xref ref-type="bibr" rid="bib1130">Tian et al., 2005</xref>). Moreover, investigations on specimens from mesial temporal lobe epilepsy (MTLE) patients have identified changes in astrocytic channels and receptors (<xref ref-type="fig" rid="fig0010">Fig. 2</xref>a–b), thus suggesting that astrocyte dysfunction can participate in hyper-excitation, neurotoxicity and seizure spreading, in addition to established neurogenic mechanisms.<fig id="fig0010"><label>Fig. 2</label><caption><p><bold>Alterations of astrocytes in CNS disorders</bold>. (a) Schematic representation of astrocyte-mediated regulation of synaptic activity in the healthy brain. (b–f) Changes of astrocytic receptors, transporters, ion channels and intracellular proteins in epilepsy (b), brain tumours (c), Alzheimer’s disease (d), major depressive disorder (<bold>e</bold>) and Down syndrome (f). Increases of expression/levels are indicated in red, decreases in blue. [AQP4: aquaporin 4; Cav: voltage-gated Ca<sup>2+</sup> channels; Cx43 and Cx30: connexins 43 and 30; GAT3: GABA transporter 3; GFAP: glial fibrillary acidic protein; GLAST and GLT1: glutamate transporters; Glu: glutamate; GS: glutamine synthetase; GJs: gap junctions; Kir4.1: inwardly-rectifying K<sup>+</sup> channels; mGluR5: metabotropic glutamate receptor 5; Nav: voltage-gated Na<sup>+</sup> channels; xCT: cysteine-glutamate system].</p></caption><alt-text id="at0490">Fig. 2</alt-text><graphic xlink:href="gr2"></graphic></fig></p>
<sec id="sec0020">
<label>3.1</label>
<title>Epilepsy-associated astrogliosis</title>
<p id="par0045">Reactive astrogliosis is present in almost all forms of epilepsy, but it is most notable in presence of hippocampal sclerosis (HS), which is often associated with MTLE and other epilepsy syndromes (<xref ref-type="bibr" rid="bib1125">Thom, 2014</xref>). Indeed, besides a severe loss of principal neurons observed in CA1 and CA3 and granule cell dispersion, HS is characterized by a chronic and fibrillary gliosis in CA1 and radial gliosis in the dentate gyrus, where the length of GFAP<sup>+</sup> fibres is directly correlated with the degree of cell dispersion in the dentate gyrus (<xref ref-type="bibr" rid="bib0320">Fahrner et al., 2007</xref>). Furthermore, in HS, together with increased conventional GFAP expression, a novel GFAP isoform has been identified in small multinucleate CA1 and CA4 astrocytes, GFAP-γ, which is speculated to regulate astrocyte size and motility (<xref ref-type="bibr" rid="bib0670">Martinian et al., 2009</xref>). Whether HS is a primary cause of epilepsy or the result of repeated epileptic seizures is still controversial. Even if the prevailing view tends to consider HS as a secondary consequence of epilepsy, experimental data on surgical samples and autoptic tissues suggest that HS aetiology is multifactorial. Febrile seizures, genetic susceptibility, alterations of hippocampal development, head injuries, infections and inflammatory and neurodevelopmental factors have indeed been identified as predisposing elements to HS development (<xref ref-type="bibr" rid="bib1030">Sendrowski and Sobaniec, 2013</xref>, <xref ref-type="bibr" rid="bib1125">Thom, 2014</xref>, <xref ref-type="bibr" rid="bib1170">Walker, 2015</xref>).</p>
</sec>
<sec id="sec0025">
<label>3.2</label>
<title>Kir channels and K<sup>+</sup> homeostasis</title>
<p id="par0050">It is well known that astrocytes are key players in the regulation of extracellular K<sup>+</sup> ([K<sup>+</sup>]<sub>o</sub>), which can transiently accumulate during prolonged neuronal activity and cause neuronal depolarization and hyper-excitability if uncompensated (<xref ref-type="bibr" rid="bib0430">Heinemann and Lux, 1977</xref>). [K<sup>+</sup>]<sub>o</sub> homeostatic control is performed by K<sup>+</sup> uptake and by spatial K<sup>+</sup> buffering: while the former is mediated by glial and neuronal Na,K-ATPase or Na-K-Cl cotransporters, the latter is driven by the difference between the glial syncytium negative membrane potential and the local K<sup>+</sup> equilibrium potential. This results in redistribution of K<sup>+</sup> from sites of high neuronal activity to sites of lower [K<sup>+</sup>]<sub>o</sub> through gap junction (GJ)-connected astrocytic networks (<xref ref-type="bibr" rid="bib0810">Orkand et al., 1966</xref>, <xref ref-type="bibr" rid="bib1175">Walz, 2000</xref>). This peculiar astrocytic property is mainly mediated by Kir4.1 K<sup>+</sup> channels, which are weakly-rectifying channels possessing a high open probability at rest and showing conductance increase at high [K<sup>+</sup>]<sub>o</sub> (<xref ref-type="bibr" rid="bib0145">Butt and Kalsi, 2006</xref>). Considering their role in K<sup>+</sup> homeostasis and since increased levels of [K<sup>+</sup>]<sub>o</sub> have been associated to the pathophysiology of epilepsy, Kir channels have been investigated in experimental (see (<xref ref-type="bibr" rid="bib0185">Chever et al., 2010</xref>, <xref ref-type="bibr" rid="bib0280">Djukic et al., 2007</xref>)) and human epilepsy. By using K<sup>+</sup>-sensitive microelectrodes, measurements of stimulus-induced [K<sup>+</sup>]<sub>o</sub> increases have been performed in human sclerotic and non-sclerotic hippocampal tissues (HS and non-HS) in presence of Ba<sup>2+</sup>, a blocker of Kir channels (<xref ref-type="bibr" rid="bib0550">Kivi et al., 2000</xref>). These recordings highlighted an impaired K<sup>+</sup> buffering in HS slices: indeed, they showed that Ba<sup>2+</sup> was able to induce [K<sup>+</sup>]<sub>o</sub> accumulation in hippocampal slices from lesion-associated TLE patients with no histopathological hippocampal alterations; on the contrary, it failed to do so in hippocampi from drug-resistant TLE patients showing strong neuronal loss and gliosis (<xref ref-type="bibr" rid="bib0350">Gabriel et al., 1998</xref>, <xref ref-type="bibr" rid="bib0435">Heinemann et al., 2000</xref>, <xref ref-type="bibr" rid="bib0500">Jauch et al., 2002</xref>, <xref ref-type="bibr" rid="bib0550">Kivi et al., 2000</xref>). Furthermore, patch-clamp recordings and single cell RT-PCR performed on human sclerotic hippocampus revealed a significant decrease (<xref ref-type="bibr" rid="bib0455">Hinterkeuser et al., 2000</xref>, <xref ref-type="bibr" rid="bib1005">Schröder et al., 2000</xref>) or a complete loss (<xref ref-type="bibr" rid="bib0090">Bordey and Sontheimer, 1998</xref>) of Kir4.1 currents; this has also been recently supported by Western blot and immunohistochemistry analysis showing a decrease of Kir4.1 protein levels in HS tissues compared to non-HS TLE patients or sudden-death controls (<xref ref-type="bibr" rid="bib0255">Das et al., 2012</xref>, <xref ref-type="bibr" rid="bib0450">Heuser et al., 2012</xref>). Thus, in HS TLE, the reduced expression and functionality of Kir4.1 channels determine an impaired K<sup>+</sup> buffering and enhance seizure susceptibility, even if it is still controversial whether this reduction is a cause or a consequence of TLE.</p>
<p id="par0055">Interestingly, several variations in human Kir4.1 gene (KCNJ10) have been identified and associated to different seizure phenotypes. Indeed, Buono and colleagues found that patients with refractory MTLE, childhood absence and juvenile myoclonic and idiopathic generalized epilepsy carried a missense mutation in the C-terminal domain of KCNJ10. Such domain is involved in ionic conductance, channel subunit dimerization and anchoring to the plasma membrane (<xref ref-type="bibr" rid="bib0135">Buono et al., 2004</xref>). Furthermore, other single nucleotide variations in non-coding regulatory KCNJ10 sequences have been found in TLE patients with febrile seizures (<xref ref-type="bibr" rid="bib0445">Heuser et al., 2010</xref>). Moreover, patients with EAST/SeSAME syndrome, an autosomal recessive multiorgan disorder characterized by seizures, ataxia, sensorineural deafness, mental retardation and electrolyte imbalance, presented loss-of-function mutations in highly conserved amino acid sequences of Kir4.1 gene, which causes impairment in channel conductance and Ba<sup>2+</sup>-sensitivity (<xref ref-type="bibr" rid="bib0085">Bockenhauer et al., 2009</xref>, <xref ref-type="bibr" rid="bib0905">Reichold et al., 2010</xref>, <xref ref-type="bibr" rid="bib1000">Scholl et al., 2009</xref>, <xref ref-type="bibr" rid="bib1210">Williams et al., 2010</xref>). Another cohort of patients displayed instead a gain-of-function mutation in KCNJ10 affecting the N-terminus and the first transmembrane region of the channel: this variation caused an increase in Kir4.1 surface expression or conductance and patients developed seizures in association with autism spectrum disorders and impaired cognitive abilities (<xref ref-type="bibr" rid="bib1060">Sicca et al., 2011</xref>).</p>
</sec>
<sec id="sec0030">
<label>3.3</label>
<title>Aquaporin-4 (AQP4)</title>
<p id="par0060">Ion homeostasis in the brain depends not only on proper functioning of ion channels, but also on water transport. The influx of water between the blood and the brain parenchyma is tightly regulated by blood vessels. Glial ensheathment of blood vessels also contributes to water influx. The movement of water across cellular compartments is mediated by aquaporins (AQPs), transmembrane proteins which act as water channels in different cells and tissues. In the brain, the predominant form is AQP4, which is localized, as Kir4.1 channels, in astrocytic perivascular endfeet and perisynaptic processes. AQP4 participates in the control of extracellular fluid osmolarity and extracellular space volume by regulating water flow and K<sup>+</sup> buffering (<xref ref-type="bibr" rid="bib0755">Nagelhus et al., 2004</xref>). It appears that water movement is altered in the hippocampus of HS TLE patients, as it has been shown that it presents an increased T2 signal density on magnetic resonance imaging and higher apparent diffusion coefficients, indicating water accumulation (<xref ref-type="bibr" rid="bib0130">Bronen et al., 1991</xref>, <xref ref-type="bibr" rid="bib0475">Hugg et al., 1999</xref>, <xref ref-type="bibr" rid="bib1195">Wieshmann et al., 1999</xref>). A potential impairment of AQP4 function has been proposed in TLE patient hippocampus: RT-PCR, immunohistochemistry and gene chip analysis have revealed an increased expression of AQP4 in HS tissues; this was accompanied by reduced levels of dystrophin, a protein involved in anchoring AQP4 to the membrane in perivascular endfeet (<xref ref-type="bibr" rid="bib0595">Lee et al., 2004</xref>). These results thus suggested an altered trafficking and distribution of AQP4 on the membranes. Quantitative electron microscopy later confirmed this hypothesis: the levels of AQP4 are indeed increased in MTLE compared to non-MTLE hippocampi. However, AQP4 density along the perivascular membrane domain of astrocytes was reduced by half in MTLE CA1 region, while no difference was found in AQP4 density on astrocyte membranes facing neuropil (<xref ref-type="bibr" rid="bib0300">Eid et al., 2005</xref>). These changes were secondary to altered perivascular dystrophin expression in sclerotic areas (<xref ref-type="bibr" rid="bib0300">Eid et al., 2005</xref>, <xref ref-type="bibr" rid="bib0595">Lee et al., 2004</xref>), which caused the loss of perivascular AQP4 and resulted in an impaired water flux through astrocytes. Given that in presence of high neuronal activity K<sup>+</sup> and water are taken up by the astrocyte membrane facing the neuropil, transported through astrocytic syncytium and siphoned into blood or CSF through perivascular endfeet membrane (<xref ref-type="bibr" rid="bib0840">Paulson and Newman, 1987</xref>), this altered flow of water affected extracellular K<sup>+</sup> buffering and contributed to epileptogenicity. Similar changes in AQP4 distribution have also been found in cortical samples of epileptic focal cortical dysplasia type IIb patients. AQP4 was indeed found to be enriched in the neuropil and around dysplastic neurons and reduced at the perivascular membranes due to disrupted dystrophin complex (<xref ref-type="bibr" rid="bib0680">Medici et al., 2011</xref>). The involvement of AQP4 in human epileptogenesis has been further confirmed by a genetic study which identified several polymorphisms of AQP4 gene associated to MTLE in combination with KCNJ10 single nucleotide polymorphisms (<xref ref-type="bibr" rid="bib0445">Heuser et al., 2010</xref>). These data support that alterations in water and K<sup>+</sup> transport contribute to the aetiology of epilepsy.</p>
</sec>
<sec id="sec0035">
<label>3.4</label>
<title>Connexin43 and gap junctions</title>
<p id="par0065">The role of GJ-connected astrocytic networks in the pathophysiology of epilepsy is still controversial, since they can act both as antiepileptic, by clearing and redistributing extracellular K<sup>+</sup>, glutamate and GABA (<xref ref-type="bibr" rid="bib0810">Orkand et al., 1966</xref>, <xref ref-type="bibr" rid="bib1175">Walz, 2000</xref>), and proepileptic, by fueling neurons with glucose and its metabolites in an activity-dependent manner (<xref ref-type="bibr" rid="bib0965">Rouach et al., 2008</xref>). Several studies have analysed changes in connexin (Cx) expression and coupling in human epileptic tissues: Naus and colleagues first reported increased Cx43 mRNA levels in the temporal cortex of epileptic patients (<xref ref-type="bibr" rid="bib0765">Naus et al., 1991</xref>). This change was confirmed by other groups both at the mRNA and protein levels (<xref ref-type="bibr" rid="bib0040">Aronica et al., 2001</xref>, <xref ref-type="bibr" rid="bib0200">Collignon et al., 2006</xref>, <xref ref-type="bibr" rid="bib0330">Fonseca et al., 2002</xref>). However, unchanged levels of Cx43 have also been reported in hippocampal tissues from patients presenting a complex partial seizure disorder in the medial temporal cortex and hippocampus (<xref ref-type="bibr" rid="bib0310">Elisevich et al., 1997</xref>). Whether expression and function of Cx30, the other astrocytic gap junction forming subunit, are altered in epilepsy remains unclear. Studies in rodents indeed report different results, which may be related to the diversity of the epilepsy models (<xref ref-type="bibr" rid="bib0005">Akbarpour et al., 2012</xref>, <xref ref-type="bibr" rid="bib0210">Condorelli et al., 2002</xref>, <xref ref-type="bibr" rid="bib0975">Söhl et al., 2000</xref>), and no data on human epileptic brain are yet available. Cx expression does not necessarily reflect active and functional coupling between astrocytes, since post-translational modifications can alter GJ properties, such as conductance, open probability and trafficking. Few functional data on GJ are available in human tissue. An early study performed <italic>in vitro</italic> on astrocytic cultures from tissues of MTLE patients reported an enhanced cell coupling by using the fluorescence recovery after photobleaching technique (<xref ref-type="bibr" rid="bib0590">Lee et al., 1995</xref>). However, recent work showed <italic>ex vivo</italic> a complete lack of glial GJ coupling in sclerotic hippocampal tissues from MTLE-HS patients, and a reduced coupling during the epileptogenic phase in the kainate mouse model of TLE (<xref ref-type="bibr" rid="bib0065">Bedner et al., 2015</xref>). It is unclear whether cultured astrocytes maintain the functional properties they display in the diseased tissue. Alternatively, gap junction coupling may be differentially regulated over the course of epilepsy, as increased astroglial coupling was found following status epilepticus in the kainate mouse (<xref ref-type="bibr" rid="bib1095">Takahashi et al., 2010</xref>).</p>
</sec>
<sec id="sec0040">
<label>3.5</label>
<title>Glutamate and GABA homeostasis</title>
<p id="par0070">Neuronal activity leads to the release of excitatory and inhibitory neurotransmitters (mainly glutamate and GABA) in the extracellular space. To ensure appropriate synaptic responses and the maintenance of excitation-inhibition balance and to avoid neuronal loss and seizures, proper glutamate and GABA removal from the synaptic cleft becomes essential. Astrocytes play a crucial role in this phenomenon through the glutamine-glutamate-GABA cycle (<xref ref-type="bibr" rid="bib0305">Eid et al., 2012</xref>): extracellular glutamate and GABA released vesicularly are taken up by astrocytes via GLAST and GLT-1 glutamate transporters and GAT3 GABA transporter, respectively. Glutamine synthetase (GS) then directly converts glutamate into glutamine, while GABA enters the TCA cycle as succinate and is subsequently converted into alpha-ketoglutarate, glutamate, and glutamine. Specialized N-transporter proteins then extrude glutamine from astrocytes into the extracellular space, while glutamatergic and GABAergic neurons import glutamine through system A transporters, and convert it to glutamate and GABA, respectively. Using <italic>in vivo</italic> microdialysis, it has been shown that MTLE patients present five-fold higher extracellular glutamate levels in the epileptic sclerotic hippocampus compared to non-HS and non-epileptic hippocampal formation, despite neuronal loss and a two-fold increase in glial density (<xref ref-type="bibr" rid="bib0155">Cavus et al., 2005</xref>, <xref ref-type="bibr" rid="bib0160">Cavus et al., 2008</xref>). This suggested that an impaired neurotransmitter homeostasis could participate in the pathophysiology of epilepsy (<xref ref-type="bibr" rid="bib0240">Coulter and Eid, 2012</xref>). Indeed, alterations of glutamate and GABA transporters as well as GS have been identified in epileptic patients.</p>
<p id="par0075">Studies on glutamate transporters in MTLE have reported contradictory results. An initial study found unchanged GLAST or GLT-1 expression through <italic>in situ</italic> hybridization and Western blot analysis in TLE hippocampus and cortex compared to post-mortem controls (<xref ref-type="bibr" rid="bib1110">Tessler et al., 1999</xref>). Similar results have also been reported in two other more recent studies (<xref ref-type="bibr" rid="bib0075">Bjørnsen et al., 2007</xref>, <xref ref-type="bibr" rid="bib0295">Eid et al., 2004</xref>). Conversely, a general decrease in GLT-1 and GLAST expression levels was found in HS TLE patients compared to non-HS TLE samples as assessed by immunocytochemical analysis (<xref ref-type="bibr" rid="bib0675">Mathern et al., 1999</xref>, <xref ref-type="bibr" rid="bib0870">Proper et al., 2002</xref>). This suggests that astrocytic glutamate uptake may play a crucial role in preventing epileptogenesis, even if the mechanism involved remains unknown.</p>
<p id="par0080">Glutamate excess in TLE patients may be explained not only by a decreased expression in glutamate transporters, but also by impaired GS function. Indeed, it has been demonstrated that there is a reduction in GS expression and functionality in astrocytes of human sclerotic hippocampi (<xref ref-type="bibr" rid="bib0295">Eid et al., 2004</xref>, <xref ref-type="bibr" rid="bib1150">van der Hel et al., 2005</xref>): this results in slower rates of glutamate-glutamine cycling, accumulation of glutamate in astrocytic cytoplasm and decreased synaptic glutamate clearance (<xref ref-type="bibr" rid="bib0850">Petroff et al., 2002</xref>). On the contrary, subiculum astrocytes still express GS, but the protein is almost absent in most of the distal astrocytic processes, compared to non-epileptic controls (<xref ref-type="bibr" rid="bib0295">Eid et al., 2004</xref>). Furthermore, genetic mutations in GS gene (GLUL) have been found in epileptic patients: two GLUL congenital homozygous mutations occurring at GS active sites have been identified in two unrelated newborns, one of them displaying severe brain malformations, almost no EEG activity except short theta bursts and generalized seizures (<xref ref-type="bibr" rid="bib0410">Haber et al., 2006</xref>, <xref ref-type="bibr" rid="bib0400">Häberle et al., 2005</xref>). Noteworthy, a third mutation has recently been found in a child affected by epileptic encephalopathy and psychomotor retardation (<xref ref-type="bibr" rid="bib0405">Häberle et al., 2011</xref>).</p>
<p id="par0085">A deficiency in GABA and GABA-mediated inhibition is thought to contribute to neuronal hyperexcitability in TLE. An <italic>in vivo</italic> microdialysis study has shown that the epileptogenic hippocampus of TLE patients presented lower extracellular GABA levels and higher glutamate concentrations just before the onset of seizures compared to the non-epileptogenic hippocampus of the same patient (<xref ref-type="bibr" rid="bib0285">During and Spencer, 1993</xref>). Interestingly, it has been demonstrated that this was due to an increased expression of the astrocytic GABA transporter GAT3, which is normally only weakly expressed in human hippocampal astrocytes (<xref ref-type="bibr" rid="bib0600">Lee et al., 2006</xref>): indeed, GAT3 was more prominently expressed in cells resembling protoplasmic astrocytes, located in dentate gyrus and hilus of sclerotic hippocampal formations. This increased GAT3 expression may thus explain GABA reduced extracellular levels during seizures, via an increased uptake by astrocytes (<xref ref-type="bibr" rid="bib0285">During and Spencer, 1993</xref>). Differently from TLE, absence epilepsy is characterized by an increased tonic GABA<sub>A</sub> receptor-mediated inhibition in thalamocortical neurons, which is necessary and sufficient for the generation of non-convulsive seizures, typical of this form of epilepsy. This alteration of GABA levels is caused by a dysfunction of GABA transporter GAT-1, which is exclusively located in astrocytes in the thalamus of both humans and rodents (<xref ref-type="bibr" rid="bib0245">Crunelli et al., 2011</xref>, <xref ref-type="bibr" rid="bib0865">Pirttimaki et al., 2013</xref>).</p>
<p id="par0090">Altogether these results indicate that an impairment of glutamate and GABA extracellular levels, due to altered expression of their transporters and reduced expression and functionality of GS, can play a major role in the pathophysiology of epilepsy.</p>
</sec>
<sec id="sec0045">
<label>3.6</label>
<title>Membrane channels</title>
<p id="par0095">Astrocytes of the sclerotic epileptic hippocampus exhibit unusual properties compared to astrocytes of other non-epileptic brain regions, due to alterations of plasma membrane channels and receptors. For instance, it has been shown that astrocytes in the hippocampus of HS-TLE patients present higher expression of metabotropic glutamatergic receptors mGluR2/3, mGluR4 and mGluR8 (<xref ref-type="bibr" rid="bib1105">Tang and Lee, 2001</xref>).</p>
<p id="par0100">Several studies using patch-clamp have also demonstrated an altered expression of voltage-gated channels in astrocytes of the epileptic hippocampus. A dramatic increase in Na<sup>+</sup> current density was indeed found in cultures of MTLE astrocytes, which displayed a depolarized membrane potential and action potential-like responses when stimulated with current injections (<xref ref-type="bibr" rid="bib0780">O’Connor et al., 1998</xref>). Similar results were also reported in human acute hippocampal slices from MTLE patients (<xref ref-type="bibr" rid="bib0090">Bordey and Sontheimer, 1998</xref>, <xref ref-type="bibr" rid="bib0095">Bordey and Spencer, 2004</xref>): in these tissues astrocytes presented complex, arborized and highly branched processes intensively stained for GFAP, and expressed high levels of TTX-sensitive Na<sup>+</sup> channels, allowing generation of slow action potentials. A significant up-regulation of the α<sub>1C</sub> subunit of voltage-gated Ca<sup>2+</sup> channels was also observed as assessed by immunohistochemistry on sclerotic TLE hippocampi (<xref ref-type="bibr" rid="bib0275">Djamshidian et al., 2002</xref>); this altered the properties of L-type Ca<sup>2+</sup> currents, suggesting an increased astrocytic Ca<sup>2+</sup> uptake.</p>
<p id="par0105">All in all, investigations of brain tissue samples from epileptic patients have revealed alterations in expression, localization and functionality of several astrocytic proteins, such as Kir4.1 channels, AQP4, Cx43, glutamate and GABA transporters. In addition, an enhanced expression of voltage-gated channels, expressed at low levels by astrocytes in the healthy brain, has also been observed in astrocytes from epileptic brain specimens. Accordingly, dysfunctional astrocytes can play a crucial role in the process of epileptogenesis and can thus be considered as alternative targets to develop new antiepileptic drugs.</p>
</sec>
</sec>
<sec id="sec0050">
<label>4</label>
<title>Brain tumours</title>
<p id="par0110">Gliomas, representing the majority of primary brain tumours, mainly originate from glial cells. They are one of the most aggressive neoplasias, since they carry a poor prognosis despite aggressive therapies due to their ability to infiltrate the brain and grow. They are classified according to the morphological properties of the tumour-forming cells (<xref ref-type="bibr" rid="bib0640">Louis et al., 2007</xref>). In particular, astrocyte-resembling cells are responsible for the development of astrocytomas, which represent the most common subtype of brain gliomas (<xref ref-type="bibr" rid="bib0340">Furnari et al., 2007</xref>). Several studies have identified astrocytic morphological and functional changes in astrocytoma, mainly affecting extracellular glutamate levels and membrane channel functions (<xref ref-type="fig" rid="fig0010">Fig. 2</xref>c).</p>
<sec id="sec0055">
<label>4.1</label>
<title>Structural and morphological changes of astrocytes</title>
<p id="par0115">Glioma cells share many characteristics with non-tumoural astrocytes, but also present several structural and morphological differences. In tissue of glioma patients, an overexpression of GFAP has been identified as being positively correlated with glioma size, but not with the degree of malignancy (<xref ref-type="bibr" rid="bib0440">Herpers et al., 1986</xref>, <xref ref-type="bibr" rid="bib0605">Lee et al., 2011a</xref>). For this reason, GFAP is used as a reliable immunohistochemical marker to stain surgically resected brain tumours in order to verify their astrocytic origin (<xref ref-type="bibr" rid="bib1165">Vinters et al., 1998</xref>). A strong GFAP immunoreactivity is present also in reactive astrocytes within or surrounding non-glial tumours (<xref ref-type="bibr" rid="bib0900">Raore et al., 2011</xref>). In grade I to IV astrocytomas, GFAP and vimentin are co-expressed but in different cellular compartments: indeed, while vimentin is located closer to cell nucleus, GFAP is preferentially detected in cellular processes (<xref ref-type="bibr" rid="bib0090">Bordey and Sontheimer, 1998</xref>, <xref ref-type="bibr" rid="bib0220">Cosgrove et al., 1989</xref>, <xref ref-type="bibr" rid="bib0440">Herpers et al., 1986</xref>). Besides GFAP, changes in other types of intermediate filament structural proteins have been observed: astrocytoma cells express the vimentin binding, 300-kDa intermediate filament associated protein (IFAP–300 kDa), which is normally present only in radial glia and immature astrocytes and absent in normal adult brain (<xref ref-type="bibr" rid="bib1240">Yang et al., 1993</xref>, <xref ref-type="bibr" rid="bib1245">Yang et al., 1994</xref>); furthermore, in astrocytomas, the proportion of keratin-containing cells, which are normally detected in the neuroectoderm, is directly linked to the degree of tumour malignancy, thus supporting a dedifferentiation of tumoural cells (<xref ref-type="bibr" rid="bib1245">Yang et al., 1994</xref>).</p>
<p id="par0120">The modified expression of cytoskeletal elements may be responsible of the altered structure of astrocytic glioma cells: indeed, compared to non-tumoural astrocytes, which present a stellate shape with 2–3 major and many smaller processes, low-grade pilocytic astrocytoma cells display only 2–3 thick processes (<xref ref-type="bibr" rid="bib0090">Bordey and Sontheimer, 1998</xref>). Furthermore, astrocytic cells in low-grade gliomas display minimal to moderate nuclear atypia, scant cytoplasm and a high nucleus-to-cytoplasm ratio (<xref ref-type="bibr" rid="bib0140">Burel-Vandenbos et al., 2011</xref>).</p>
</sec>
<sec id="sec0060">
<label>4.2</label>
<title>Extracellular glutamate</title>
<p id="par0125">Extracellular glutamate concentration is elevated in tumoural and peritumoural regions, especially close to tumours containing necrotic areas in high-grade astrocytoma patients (<xref ref-type="bibr" rid="bib0940">Roslin et al., 2003</xref>). Similar results have also been observed in oligodendrogliomas, which present high levels of glutamate and glutamine in the peritumoural area, as assessed by magnetic resonance spectroscopy (<xref ref-type="bibr" rid="bib0920">Rijpkema et al., 2003</xref>). This altered glutamate homeostasis explains why during the time course of the disease, 60–80% of glioma patients experience seizures (<xref ref-type="bibr" rid="bib0575">Kurzwelly et al., 2010</xref>, <xref ref-type="bibr" rid="bib0645">Lynam et al., 2007</xref>), which originate close to the tumour mass (<xref ref-type="bibr" rid="bib0825">Pallud et al., 2013</xref>, <xref ref-type="bibr" rid="bib0835">Patt et al., 2000</xref>). Various studies aiming at identifying the source of peritumoural glutamate reported an impaired expression of glutamate transporters on glioma cells: brain tissues from glioblastoma patients indeed display a strong reduction in GLT-1 levels, while GLAST is normally expressed but is thought to be mislocalized in cell nuclei rather than at the plasma membrane (<xref ref-type="bibr" rid="bib0645">Lynam et al., 2007</xref>, <xref ref-type="bibr" rid="bib0985">Savaskan et al., 2008</xref>, <xref ref-type="bibr" rid="bib1255">Ye et al., 1999</xref>). Decreased GLT-1 levels have also been observed in high-grade compared to low-grade astrocytomas and normal brains (<xref ref-type="bibr" rid="bib0265">de Groot et al., 2005</xref>). Furthermore these changes are accompanied by an altered expression of the cysteine-glutamate system (xc system), a Na<sup>+</sup>-independent exchanger that controls the intracellular glutathione levels by importing one molecule of extracellular cysteine (required in glutathione synthesis) per released glutamate. Glioma cell lines originated from tumours and brain specimens from glioblastoma patients express the xc system at significantly higher levels compared to human tissue samples without malignant transformation (<xref ref-type="bibr" rid="bib0985">Savaskan et al., 2008</xref>, <xref ref-type="bibr" rid="bib1255">Ye et al., 1999</xref>). Furthermore, a recent study has shown that 50% of patient-derived gliomas have elevated expression of SLC7A11, the catalytic subunit of the xc system responsible for xc-mediated glutamate release (<xref ref-type="bibr" rid="bib0930">Robert et al., 2015</xref>). Interestingly, when these glioma cells implanted intracranially in mice propagated <italic>in vivo</italic> as flank tumour xenolines, they caused seizures, tumour-associated excitotoxicity and shortened survival. Altogether these results thus suggest that high levels of this system contribute to the release of cytotoxic glutamate levels, which promote seizures and act as an autocrine/paracrine signal sustaining tumour growth and invasion (<xref ref-type="bibr" rid="bib0650">Lyons et al., 2007</xref>).</p>
</sec>
<sec id="sec0065">
<label>4.3</label>
<title>Gap-junctions and membrane ion channels</title>
<p id="par0130">Normal growth and metabolism of cells depend not only on their organelles and subcellular structures, but also on cell-to-cell communication, in which GJs play a fundamental role. Impairment of GJ-mediated intercellular communication may indeed result in aberrant growth and tumour development (<xref ref-type="bibr" rid="bib0800">Omori and Yamasaki, 1998</xref>). Noteworthy, low-grade gliomas present a strong Cx43 immunoreactivity, particularly in reactive astrocytes of the peritumoural area; on the contrary, in surgical specimen from high-grade astrocytoma patients Cx43 levels are reduced both on membranes and in the cytoplasm. In addition, only the non-phosphorylated isoform of Cx43 was detected (<xref ref-type="bibr" rid="bib0040">Aronica et al., 2001</xref>). Similar results have also been observed in primary astrocytic cultures from glioblastoma multiform patients (<xref ref-type="bibr" rid="bib1085">Soroceanu et al., 2001</xref>), where reduced Cx43 expression and GJ-mediated coupling were found. Interestingly, the decrease in Cx43 expression is proportional to tumour grade and proliferative capacity (<xref ref-type="bibr" rid="bib0875">Pu et al., 2004</xref>), and is not due to a reduced genetic transcription: grade III and IV gliomas indeed present elevated Cx43 mRNA but low proteins levels (<xref ref-type="bibr" rid="bib0150">Caltabiano et al., 2010</xref>), suggesting an alteration in post-transcriptional mechanisms in glioma astrocytic cells.</p>
<p id="par0135">Besides GJ channels, astrocytic tumoural cells present changes in the expression of Na<sup>+</sup> and K<sup>+</sup> channels: low-grade pilocytic astrocytoma cells indeed display almost exclusively delayed rectifying K<sup>+</sup> currents, while no transient A-type and inwardly rectifying K<sup>+</sup> channels were detected. Alteration in K<sup>+</sup> channel-dependent cell volume regulation resulted in a depolarized membrane potential and a round swollen cell body. Furthermore, these cells have increased TTX-sensitive Na<sup>+</sup> currents, which enable them to generate spike-like events after current injections (<xref ref-type="bibr" rid="bib0090">Bordey and Sontheimer, 1998</xref>). Alterations in Na<sup>+</sup> channel expression have also been found in high-grade gliomas. Pleomorphic GFAP<sup>+</sup> cells and hypertrophic reactive astrocytes adjacent to multiform glioblastoma showed strong Nav1.5 expression in cell bodies and processes, compared to astrocytes in normal white matter (<xref ref-type="bibr" rid="bib0080">Black et al., 2010</xref>).</p>
<p id="par0140">Malignant astrocytic gliomas, characterized by uncontrolled cellular proliferation and diffuse infiltration, show an intense resistance to apoptosis, which contributes to the ineffectiveness of traditional therapeutic approaches (such as surgical resection, radiotherapy and chemotherapy). Astrocytes in these cancers display morphological changes and increased GFAP expression, two phenotypes that have been described in activated astrocytes after a CNS injury. Moreover, GJ coupling is reduced: this favors malignant transformation via a reduction of inhibitory signals controlling cell division and proliferation received from neighbouring cells. Glioma astrocytes also present impaired extracellular glutamate regulation and aberrant expression of voltage-gated channels, contributing to aberrant neuronal and astrocytic activity. In order to consider these dysregulated astrocytic pathways as potential therapeutical targets, it is of crucial importance to understand how glioma cells modify during tumour progression and interact with neighbouring normal and cancerous cells in the tumour microenvironment.</p>
</sec>
</sec>
<sec id="sec0070">
<label>5</label>
<title>Alzheimer’s disease</title>
<p id="par0145">Alzheimer’s disease (AD) is the most common type of dementia in elderly, accounting for 60–80% of dementia patients (<xref ref-type="bibr" rid="bib1225">Wortmann, 2012</xref>). It is characterized by a subtle decline in episodic memory, appearing as a deficit in recalling the recent past, followed by a more global decline of cognitive abilities, such as loss of long-term memories, language, attention and personality changes (<xref ref-type="bibr" rid="bib0880">Querfurth and LaFerla, 2010</xref>). AD is identified by two histopathological hallmarks, extracellular deposits (plaques) of amyloid-beta (Aβ) protein and intracellular neuronal tangles formed by abnormally phosphorylated tau protein (<xref ref-type="bibr" rid="bib0880">Querfurth and LaFerla, 2010</xref>). The distribution pattern of neurofibrillary tangles and neuronal alterations are generally used to define the stage of AD progression (<xref ref-type="bibr" rid="bib0110">Braak and Braak, 1991</xref>, <xref ref-type="bibr" rid="bib0115">Braak and Braak, 1995</xref>). In stages I and II, neuronal alterations are confined to the transentorhinal region, while both the entorhinal/transentorhinal areas and hippocampus are involved in stages III and IV. The last stages of AD progression (V and VI) are instead marked by devastating neocortical distruction and represent the fully developed AD (<xref ref-type="bibr" rid="bib0115">Braak and Braak, 1995</xref>). Despite the global economic burden of this disease, effective treatments are still lacking and the causes of the disease remain elusive. The pathological potential of astrocytes in AD has been initially suggested in 1910 by Alois Alzheimer, who found glial cells in closed association with damaged neurons and abundantly populating senile plaques (<xref ref-type="bibr" rid="bib1160">Verkhratsky et al., 2010</xref>). This has been subsequently confirmed by studies on human tissues and AD animal models showing astrocytic hypertrophy, particularly in astrocytes associated with senile plaques (<xref ref-type="bibr" rid="bib0750">Nagele et al., 2004</xref>), as well as glial changes often preceding plaque and tangle formation (<xref ref-type="bibr" rid="bib0935">Rodríguez-Arellano et al., 2016</xref>) (<xref ref-type="fig" rid="fig0010">Fig. 2</xref>d).</p>
<sec id="sec0075">
<label>5.1</label>
<title>Astrogliosis in AD</title>
<p id="par0150">Reactive astrogliosis is a well-known hallmark of AD, even if its role has not been clearly understood yet. It is identified by an increased expression of GFAP and hypertrophy of astrocytes in the vicinity of amyloid plaques. Post-mortem tissues from AD patients indeed display increased GFAP levels in temporal (<xref ref-type="bibr" rid="bib0385">Griffin et al., 1989</xref>, <xref ref-type="bibr" rid="bib1065">Simpson et al., 2010</xref>), occipital, parietal and frontal lobes (<xref ref-type="bibr" rid="bib0530">Kashon et al., 2004</xref>). Moreover, in the cerebrospinal fluid of AD patients, higher levels of GFAP concentrations have been measured compared to age-matched controls (<xref ref-type="bibr" rid="bib0505">Jesse et al., 2009</xref>). Interestingly, some degree of correlation has been found between GFAP expression and AD progression, with higher GFAP levels at increasing Braak groups (<xref ref-type="bibr" rid="bib1065">Simpson et al., 2010</xref>) or duration of clinical illness (<xref ref-type="bibr" rid="bib1040">Serrano-Pozo et al., 2013</xref>). However, this correlation remains uncertain, since another work showed no difference in GFAP expression between demented and non-demented brains within the same Braak stage (<xref ref-type="bibr" rid="bib1185">Wharton et al., 2009</xref>). During AD progression, 8 of the 10 different GFAP isoforms described (<xref ref-type="bibr" rid="bib0465">Hol and Pekny, 2015</xref>) are upregulated. For instance, reactive astrocytes in dentate gyrus subgranular zone, hilus and CA4 area of AD patients display a prominent expression of GFAPδ, but only CA1, CA3 and subiculum astrocytes surrounding plaques showed GFAPδ upregulation with increasing AD stage (<xref ref-type="bibr" rid="bib0520">Kamphuis et al., 2014</xref>). Additionally, the number of human-specific astrocyte subtypes expressing the frame-shifted GFAP variant, GFAP<sup>+1</sup>, is increased with AD progression, but only few of these GFAP<sup>+1</sup>-expressing cells has been identified as associated to plaques, with processes protruding through them (<xref ref-type="bibr" rid="bib0520">Kamphuis et al., 2014</xref>, <xref ref-type="bibr" rid="bib0695">Middeldorp et al., 2009</xref>). Astrogliosis and GFAP upregulation are also accompanied by dysregulation in the expression of other astrocytic cytoskeleton proteins. For instance, in the lateral temporal cortex of advanced AD stages, there is a significant decrease in transcripts encoding members of the myosin and kinesin family and other cytoskeletal proteins, such as actin β, dynein and integrin α. Moreover, transcripts encoding tight junction proteins and adherens junctions are also reduced during AD progression (<xref ref-type="bibr" rid="bib1070">Simpson et al., 2011</xref>). The effect of the altered expression of these genes in astrocytes still remains unclear, but it may affect various intracellular signalling pathways.</p>
</sec>
<sec id="sec0080">
<label>5.2</label>
<title>Interactions between astrocytes and Aβ</title>
<p id="par0155">In AD brains at early stages of the pathology, activated reactive astrocytes are predominant in the molecular layer of the cerebral cortex and close to amyloid plaques in pyramidal cell layers (<xref ref-type="bibr" rid="bib1215">Wisniewski and Wegiel, 1991</xref>). In several brain regions such as cortex, hippocampus and cerebellum, proliferating processes of hypertrophic astrocytes nearest to amyloid deposits contact and surround the plaques; they penetrate more into non-cored primitive plaques, compared to classic compact cored amyloid deposits, thus merging with them and contributing to their fragmentation, dispersion and the observed variety of plaque morphology (<xref ref-type="bibr" rid="bib0535">Kato et al., 1998</xref>, <xref ref-type="bibr" rid="bib1215">Wisniewski and Wegiel, 1991</xref>). Interestingly, in the visual cortex of AD brains with severe pathology, GFAP-immunoreactive astrocytes and plaques are arranged in a specific laminar distribution: indeed gliosis is preferentially localized in laminae II, III, IVa and IVc, the latter presenting a discrete plaque-associated glyotic horizontal band at the lower edge (<xref ref-type="bibr" rid="bib0055">Beach and McGeer, 1988</xref>). Furthermore, a more recent study has shown that reactive astrocytes together with microglial cells form specific 3D reactive glial nets around plaques in a plaque-specific way: at Aβ dense-core plaques, astrocytic processes are intermingled with microglial cell bodies which envelop the core Aβ structure; while at fibrillary plaques, a higher number of glial cells are recruited to reactive glial net formation and both microglial and astrocytic processes invade the plaque area and interact with Aβ protein (<xref ref-type="bibr" rid="bib0100">Bouvier et al., 2016</xref>).</p>
<p id="par0160">The stimulus capable of inducing astrocyte reactivity in AD brains is still under debate; however, studies using aggregated Aβ protein and the intact core of Aβ plaques isolated from AD brain tissue have shown that Aβ can trigger activation of astrocytes <italic>in vitro</italic>, causing GFAP up-regulation and morphological changes (<xref ref-type="bibr" rid="bib0270">DeWitt et al., 1998</xref>). Furthermore, amyloid plaques colocalize with reactive astrocytes in the absence of dystrophic neurites in the hippocampus of mild AD brains, while decreasing over the course of the pathology (<xref ref-type="bibr" rid="bib0860">Pike et al., 1995</xref>). This suggests that plaque-associated astrocytosis can act as a contributory event in AD pathology and that once activated, astrocytes can participate in Aβ metabolism. Aβ42 indeed accumulates in the cytoplasm and processes of reactive astrocytes in the molecular layer completely devoid of amyloid plaques in AD brains. Aβ42 also builds up in astrocytes associated with plaques in pyramidal cell layers of the entorhinal, parietal, occipital and temporal cortex (<xref ref-type="bibr" rid="bib0010">Akiyama et al., 1999</xref>, <xref ref-type="bibr" rid="bib0335">Funato et al., 1998</xref>, <xref ref-type="bibr" rid="bib0570">Kurt et al., 1999</xref>, <xref ref-type="bibr" rid="bib0745">Nagele et al., 2003</xref>, <xref ref-type="bibr" rid="bib1115">Thal et al., 1999</xref>, <xref ref-type="bibr" rid="bib1120">Thal et al., 2000</xref>). In these cells, non-fibrillar Aβ42 localizes to small lysosomal lipofuscin-like granules, organized in clusters and mainly located in the perinuclear cytoplasm (<xref ref-type="bibr" rid="bib0335">Funato et al., 1998</xref>, <xref ref-type="bibr" rid="bib0745">Nagele et al., 2003</xref>, <xref ref-type="bibr" rid="bib1115">Thal et al., 1999</xref>, <xref ref-type="bibr" rid="bib1235">Yamaguchi et al., 1998</xref>). Moreover, it has recently been reported that more than 90% of activated astrocytes in AD brain frontal cortex can accumulate a newly described class of amyloid structures formed by Aβ, the annular protofibrils. These fibrils are absent in amyloid plaques and in the brain of age-matched controls, and can induce reactive oxygen species generation and inactivation of GS in the cell (<xref ref-type="bibr" rid="bib0580">Lasagna-Reeves and Kayed, 2011</xref>).</p>
<p id="par0165">The accumulation of Aβ42 in astrocytes is directly linked to the severity of local AD pathology. Aβ42<sup>+</sup> material in astrocytes is indeed proportional to the amount of Aβ42 contained in surrounding neurons and to the local density of amyloid plaques within the pyramidal cell layer of the entorhinal cortex, while the amount of Aβ42 in astrocytes of the molecular layer devoid of plaques well correlates with the severity of the pathology in the sub-adjacent cortical laminae (<xref ref-type="bibr" rid="bib0745">Nagele et al., 2003</xref>). Interestingly, astrocyte-accumulated Aβ42 is not produced by astrocytes, but has a neuronal origin, deriving from the internalization of degenerating synapses and dendrites by phagocytosis: astrocytic Aβ42 colocalizes with choline acetyltransferase and α7 nicotinic acetylcholine receptors, which are neuron-specific proteins accumulating in astrocytes as a consequence of their debris-clearing activity (<xref ref-type="bibr" rid="bib0750">Nagele et al., 2004</xref>). Furthermore, with the progression of the disease, Aβ42-burdened astrocytes can undergo lysis and form small spherical GFAP<sup>+</sup> amyloid plaques, first appearing in the subpial portion of the cortical molecular layer close to astrocytes containing large Aβ42 deposits (<xref ref-type="bibr" rid="bib0745">Nagele et al., 2003</xref>).</p>
<p id="par0170">These results indicate that not only neurons, but also astrocytes are capable of giving rise to amyloid plaques and causing morphological modifications within these plaques; this ability can thus account, at least in part, for the variety of plaque morphology identified in AD brains. Blocking the initial accumulation of Aβ42 in neurons represents the main early target to control AD pathology. However, in view of the ability of astrocytes to interact with plaques and participate in Aβ metabolism, limiting their recruitment could also contribute to limiting or delaying AD progression.</p>
</sec>
<sec id="sec0085">
<label>5.3</label>
<title>Glutamate and GABA homeostasis</title>
<p id="par0175">There are several indications that astrocytic glutamatergic function is impaired in AD. GLT-1 immunoreactivity is reduced in the frontal cortex of AD patients (<xref ref-type="bibr" rid="bib0630">Li et al., 1997</xref>, <xref ref-type="bibr" rid="bib1135">Tian et al., 2010</xref>) and this reduction is inversely correlated with amyloid precursor protein mRNA levels, while no change has been observed for GLAST expression. GLT-1 reduced expression is also accompanied by decreased glutamatergic transport activity and increased mRNA levels, thus indicating an impairment at post-transcriptional level (<xref ref-type="bibr" rid="bib0630">Li et al., 1997</xref>). Similar results have also been obtained in the hippocampus and gyrus frontalis of AD patient brains. A marked impairment in GLT-1 and GLAST expression at both gene and protein levels occur already at early stages of the disease, particularly in the vicinity of amyloid plaques (<xref ref-type="bibr" rid="bib0495">Jacob et al., 2007</xref>). Furthermore, in AD lateral temporal cortex, GLT-1 expression tends to decrease with higher Braak group. This correlation is however still under debate, since contradictory results have been obtained due to high variability of glutamate transporter expression between AD individuals (<xref ref-type="bibr" rid="bib0060">Beckstrøm et al., 1999</xref>). Together with reduced expression, protein splice variants can also account for changes in the functionality of glutamate transporters. Interestingly, disease- and pathology-specific changes in GLT-1 splice variant expression occur in autoptic AD brains, which can account for the reduced astrocytic glutamate uptake efficiency in AD. In particular, a reduction in the functional splice variants b, which is able to uptake glutamate, has been identified in several brain regions, together with a significant increase of exon-skipping variants, characterized by reduced transport capacity (<xref ref-type="bibr" rid="bib1020">Scott et al., 2011</xref>). Altogether, these results suggest an impairment of astrocytic glutamate clearance capability in AD, which may lead to neurotoxic effect and contribute to the increased prevalence of seizures in AD patients (<xref ref-type="bibr" rid="bib0990">Scarmeas et al., 2009</xref>).</p>
<p id="par0180">Furthermore, the levels of GS are also altered in AD brain: temporal neocortex astrocytes from AD brain samples display reduced GS expression due to impairment of post-translational modifications, which renders the protein highly sensitive to oxidative lesioning (<xref ref-type="bibr" rid="bib0585">Le Prince et al., 1995</xref>). In contrast, total GS levels in the CSF of AD patients remain unchanged (<xref ref-type="bibr" rid="bib1140">Timmer et al., 2015</xref>).</p>
<p id="par0185">GABAergic dysfunction also plays a role in AD, and several recent studies point to abnormalities of GABA homeostasis in reactive AD astrocytes. An accumulation of GABA together with an increase in GAD67 and GAT3 have been found in GFAP<sup>+</sup> astrocytes of dentate gyrus molecular layer and inferior temporal cortex from post-mortem AD patients, but not in age-related healthy subjects (<xref ref-type="bibr" rid="bib0725">Mitew et al., 2013</xref>, <xref ref-type="bibr" rid="bib1230">Wu et al., 2014</xref>). This suggests an increased GABA production in astrocytes. Consistent with this hypothesis, astrocytic monoamine oxidase-B, the enzyme responsible for GABA production, is up-regulated in post-mortem brains of AD individuals. This has also been shown in AD mouse models, where accumulating GABA is abnormally released from reactive astrocytes through bestrophin 1 channels, which impairs learning and memory (<xref ref-type="bibr" rid="bib0510">Jo et al., 2014</xref>) The high astrocytic GABA level identified in human brains with high Aβ load may thus be used as a novel biomarker and diagnostic tool for AD. Furthermore, since it has been shown that GABA transporters can reverse their transport direction in presence of excessive intracellular GABA (<xref ref-type="bibr" rid="bib0610">Lee et al., 2011b</xref>, <xref ref-type="bibr" rid="bib0915">Richerson and Wu, 2003</xref>), GAT3 may serve as a new drug target.</p>
</sec>
<sec id="sec0090">
<label>5.4</label>
<title>Astrocyte-specific protein changes</title>
<p id="par0190">Not only are glutamate and GABA homeostasis altered in AD, but also other astrocytic-specific functions, such as GJ communication and K<sup>+</sup> buffering. In 1996 Nagy and colleagues reported for the first time an increased Cx43 expression in temporal cortical areas containing several amyloid plaques in post-mortem AD human brains. Furthermore, they also demonstrated using electron microscopy that the enhanced Cx43 immunoreactivity was restricted to astrocytic GJs throughout the tissue, both within and outside plaque-containing regions (<xref ref-type="bibr" rid="bib0760">Nagy et al., 1996</xref>). This observation was later confirmed, as a similar enrichment of Cx43 puncta occurred in reactive astrocytic processes infiltrating amyloid plaques, together with a milder increase of Cx30 (<xref ref-type="bibr" rid="bib0560">Koulakoff et al., 2012</xref>). AD brain tissues also display altered Kir4.1 and AQP4 expression (<xref ref-type="bibr" rid="bib1200">Wilcock et al., 2009</xref>): a strong decrease in Kir4.1 and AQP4 mRNA levels occur in the temporal cortex of brain samples from AD patients with moderate and severe pathology. Furthermore AQP4 is also mislocalized, and presents a diffuse staining pattern with poorly distinguishable blood vessels in severe pathology cases (<xref ref-type="bibr" rid="bib1200">Wilcock et al., 2009</xref>). A significant increase in AQP1, normally expressed in the choroid plexus, has been identified in astrocytes of the frontal cortex and temporal lobes in sporadic and familial AD cases, where AQP1<sup>+</sup> astrocytes were found close to Aβ42 or Aβ40 deposits (<xref ref-type="bibr" rid="bib0470">Hoshi et al., 2012</xref>, <xref ref-type="bibr" rid="bib0820">Pérez et al., 2007</xref>).</p>
<p id="par0195">A deregulation of cellular Ca<sup>2+</sup> levels has been proposed to contribute to the initial steps of AD progression, by causing a long-lasting overload in the cytoplasm and the endoplasmic reticulum, which triggers cell death. Although this signalling was considered compromised mainly in neurons, astrocytes are also affected as demonstrated in rodent AD models and AD human brain samples. Basal Ca<sup>2+</sup> levels are indeed elevated in the astrocytic network and Ca<sup>2+</sup> transients are more frequent, coordinated across long distances and independent from neuronal activity in the cortex of AD mice (<xref ref-type="bibr" rid="bib0565">Kuchibhotla et al., 2009</xref>). An enhanced Ca<sup>2+</sup> response may be the result of an altered expression of astrocytic metabotropic glutamate receptor 5 (mGluR5). Indeed, an increased mGluR5 staining has been identified in hippocampal astrocytes of AD patients, in proximity of Aβ plaques (<xref ref-type="bibr" rid="bib0635">Lim et al., 2013</xref>). Furthermore, changes in S100β levels have been identified in AD patients: while S100β is strongly overexpressed in AD hippocampal and temporal lobe astrocytes closely associated with either diffuse or neuritic Aβ plaques, only moderate increases have been found in frontal lobe and pons and unchanged levels in occipital lobe and cerebellum (<xref ref-type="bibr" rid="bib0385">Griffin et al., 1989</xref>, <xref ref-type="bibr" rid="bib0665">Marshak et al., 1992</xref>, <xref ref-type="bibr" rid="bib1155">Van Eldik and Griffin, 1994</xref>). In the temporal lobe from AD human brain, S100β-overexpressing astrocytes are mainly associated with diffuse neuritic plaques, while diffuse non-neuritic and dense-core neuritic plaques have small numbers of associated S100β astrocytes. Astrocytes were observed in close proximity to dense-core non-neuritic plaques only rarely (<xref ref-type="bibr" rid="bib0735">Mrak et al., 1996</xref>). This indicates that activated astrocytes producing S100β are present already during the earliest stages of plaque formation, and decrease at the end-stage of plaque progression. Furthermore, a correlation has been found between neuritic plaque density and S100β levels, which are significantly increased in the brain of AD patients compared to age-matched controls (<xref ref-type="bibr" rid="bib0735">Mrak et al., 1996</xref>). The number of activated S100β-overexpressing astrocytes associated with single neuritic plaques and the degree of neuritic pathology in the same plaques are also correlated (<xref ref-type="bibr" rid="bib0735">Mrak et al., 1996</xref>, <xref ref-type="bibr" rid="bib1045">Sheng et al., 1994</xref>, <xref ref-type="bibr" rid="bib1050">Sheng et al., 1996</xref>). Remarkably, AD mice also display enhanced glutamatergic gliotransmission, as indicated by the increased frequency in resting conditions of the slow inward currents mediated by activation of NMDA receptors in neurons (<xref ref-type="bibr" rid="bib0345">Gómez-Gonzalo et al., 2017</xref>). Furthermore, astrocytic Ca<sup>2+</sup> signals can be protective during the initial phase of AD, since the disruption of inositol triphosphate receptors 2 (IP3R2)-mediated Ca<sup>2+</sup> signalling in astrocytes boosted the progression of Aβ plaque deposition and synaptic plasticity dysfunction at very early stages of the pathology (<xref ref-type="bibr" rid="bib0345">Gómez-Gonzalo et al., 2017</xref>).</p>
<p id="par0200">During AD progression, astrocytes display a complex pattern of dysfunctions, concerning cytoskeleton, cell junctions, gap junction communication, intracellular signalling molecules and neurotransmitter homeostasis. These pathways are progressively affected with increasing Braak stages of the pathology, thus suggesting a continuous decline of astrocyte functions in AD. Further investigations are now required to clarify whether and which of these changes play an active role in AD development. This will be crucial in designing new therapies aimed at rescuing astrocytic physiological functions that may limit or even prevent AD-associated cognitive decline.</p>
</sec>
</sec>
<sec id="sec0095">
<label>6</label>
<title>Major depressive disorder</title>
<p id="par0205">Major depressive disorder (MDD), a chronic recurrent and debilitating mental illness, is characterized by depressed mood, loss of interest and pleasure, weight changes, sleep alterations, loss of energy, difficulties of concentration and thought of death and suicide (<xref ref-type="bibr" rid="bib0025">American Psychiatric Association, 2013</xref>). Numerous studies have revealed that MDD is a disorder with prominent pathological astrocytic alterations, which affect density, morphology, protein expression and membrane channel functions of astrocytes (<xref ref-type="fig" rid="fig0010">Fig. 2</xref>e). However, astrocytic changes in MDD strongly differ from what is observed in other neurological and neurodegenerative disorders, such as epilepsy, inflammation and Alzheimer’s disease: while these diseases present reactive astrogliosis, glial scar formation and neuronal loss (<xref ref-type="bibr" rid="bib1080">Sofroniew, 2009</xref>, <xref ref-type="bibr" rid="bib1075">Sofroniew and Vinters, 2010</xref>), astrogliosis and prominent neuronal pathology is not present in MDD.</p>
<sec id="sec0100">
<label>6.1</label>
<title>Astrocyte density and morphology</title>
<p id="par0210">Many histopathological studies performed on post-mortem brain samples have unveiled prominent decreases in astrocyte number and packing density in MDD subjects compared to age-matched non-psychiatric controls (<xref ref-type="bibr" rid="bib0230">Cotter et al., 2002</xref>, <xref ref-type="bibr" rid="bib0225">Cotter et al., 2001</xref>, <xref ref-type="bibr" rid="bib0360">Gittins and Harrison, 2011</xref>, <xref ref-type="bibr" rid="bib0805">Ongür et al., 1998</xref>, <xref ref-type="bibr" rid="bib0885">Rajkowska et al., 1999</xref>). Several brain regions display a reduced astrocytic population, such as dorsolateral prefrontal (<xref ref-type="bibr" rid="bib0230">Cotter et al., 2002</xref>, <xref ref-type="bibr" rid="bib0885">Rajkowska et al., 1999</xref>), orbitofrontal (<xref ref-type="bibr" rid="bib0885">Rajkowska et al., 1999</xref>), subgenual (<xref ref-type="bibr" rid="bib0805">Ongür et al., 1998</xref>) and anterior cingulate cortex (<xref ref-type="bibr" rid="bib0225">Cotter et al., 2001</xref>) and amygdala (<xref ref-type="bibr" rid="bib0020">Altshuler et al., 2010</xref>, <xref ref-type="bibr" rid="bib0105">Bowley et al., 2002</xref>). However, an increase in glial cell density has also been reported in hippocampal regions and dentate gyrus of MDD patients (<xref ref-type="bibr" rid="bib1090">Stockmeier et al., 2004</xref>), while no change has been observed in the orbitofrontal cortex and in the supragenual region of the anterior cingulate cortex in late-life depressed patients (<xref ref-type="bibr" rid="bib0540">Khundakar et al., 2011a</xref>, <xref ref-type="bibr" rid="bib0545">Khundakar et al., 2011b</xref>) and in the hippocampus (<xref ref-type="bibr" rid="bib0195">Cobb et al., 2013</xref>). Changes in glial density may thus differentially affect specific brain regions. Interestingly, it has been shown that this alteration is age-dependent: in grey matter of dorsolateral prefrontal cortex of younger depressed patients (&lt;50 years old), the density of GFAP<sup>+</sup> astrocytes is significantly reduced compared to controls of similar age; in contrast, older subjects with late-onset depression presented increased astrocytic population in the same area (<xref ref-type="bibr" rid="bib0700">Miguel-Hidalgo et al., 2000</xref>), probably reflecting a compensation to neuronal loss observed in older MDD patients (<xref ref-type="bibr" rid="bib0890">Rajkowska et al., 2005</xref>).</p>
<p id="par0215">In parallel to alterations of astrocyte packing density, the size of glial nuclei seems to be affected in MDD. Astrocytes with larger nuclei have been observed in the dorsolateral prefrontal cortex (<xref ref-type="bibr" rid="bib0885">Rajkowska et al., 1999</xref>) and in the grey and white matter of the anterior cingulate cortex: in these regions fibrous astrocytes had bigger cell bodies and more ramified processes in depressed subjects committing suicide compared to matched sudden-death controls (<xref ref-type="bibr" rid="bib0165">Chana et al., 2003</xref>, <xref ref-type="bibr" rid="bib1145">Torres-Platas et al., 2011</xref>). On the contrary, three other studies observed unaltered glial size in the prefrontal and orbitofrontal cortex and in the hippocampus (<xref ref-type="bibr" rid="bib0230">Cotter et al., 2002</xref>, <xref ref-type="bibr" rid="bib0235">Cotter et al., 2005</xref>, <xref ref-type="bibr" rid="bib1090">Stockmeier et al., 2004</xref>).</p>
<p id="par0220">Studies on GFAP expression additionally revealed marked alterations in MDD subjects. Immunohistochemical analysis aimed at quantifying the area covered by GFAP<sup>+</sup> cell bodies and processes has shown a predominant decrease of GFAP in grey matter of the prefrontal cortex in young depressed subjects compared to controls (<xref ref-type="bibr" rid="bib0700">Miguel-Hidalgo et al., 2000</xref>), in white matter of anterior cingulate cortex (<xref ref-type="bibr" rid="bib0360">Gittins and Harrison, 2011</xref>), in orbitofrontal cortex (<xref ref-type="bibr" rid="bib0705">Miguel-Hidalgo et al., 2010</xref>), CA1 and CA2 hippocampal regions (<xref ref-type="bibr" rid="bib0655">Müller et al., 2001</xref>), locus coeruleus (<xref ref-type="bibr" rid="bib0170">Chandley et al., 2013</xref>) and cerebellum (<xref ref-type="bibr" rid="bib0325">Fatemi et al., 2004</xref>). Moreover, GFAP decrease has also been confirmed at mRNA and protein levels (<xref ref-type="bibr" rid="bib0170">Chandley et al., 2013</xref>, <xref ref-type="bibr" rid="bib0325">Fatemi et al., 2004</xref>, <xref ref-type="bibr" rid="bib0515">Johnston-Wilson et al., 2000</xref>, <xref ref-type="bibr" rid="bib0700">Miguel-Hidalgo et al., 2000</xref>, <xref ref-type="bibr" rid="bib1180">Webster et al., 2005</xref>) and it is correlated with age and onset of depression: the levels of GFAP protein are indeed significantly lower in less than 60 years-old depressed patients compared to age-matched controls, with no change observed between older MDD subjects and their controls (<xref ref-type="bibr" rid="bib1055">Si et al., 2004</xref>). In contrast, an increase of GFAP occurred in dorsolateral prefrontal cortex in late-onset MDD patients (<xref ref-type="bibr" rid="bib0260">Davis et al., 2002</xref>, <xref ref-type="bibr" rid="bib0700">Miguel-Hidalgo et al., 2000</xref>).</p>
</sec>
<sec id="sec0105">
<label>6.2</label>
<title>Glutamate and GABA homeostasis</title>
<p id="par0225">Recent neuroimaging and post-mortem studies on depressed subjects have revealed a dysfunction of astrocytic-mediated regulation of glutamate homeostasis. MDD subjects presented lower levels of glutamate, glutamine or combined glutamate/glutamine (Glx), as assessed by magnetic resonance spectroscopy, in several brain regions such as prefrontal areas (<xref ref-type="bibr" rid="bib0425">Hasler et al., 2007</xref>), frontal lobe (<xref ref-type="bibr" rid="bib1260">Yildiz-Yesiloglu and Ankerst, 2006</xref>), anterior cingulate cortex (<xref ref-type="bibr" rid="bib0045">Auer et al., 2000</xref>, <xref ref-type="bibr" rid="bib0720">Mirza et al., 2004</xref>, <xref ref-type="bibr" rid="bib0855">Pfleiderer et al., 2003</xref>) and amygdala (<xref ref-type="bibr" rid="bib0690">Michael et al., 2003</xref>), and in plasma (<xref ref-type="bibr" rid="bib0015">Altamura et al., 1995</xref>). This suggests an impaired glutamate/glutamine metabolism. These changes may however not appear homogenously in all brain areas and in all depressed patients, since two other studies reported glutamate increases in occipital and frontal cortex (<xref ref-type="bibr" rid="bib0420">Hashimoto et al., 2007</xref>, <xref ref-type="bibr" rid="bib0980">Sanacora et al., 2004</xref>), probably reflecting region-specific alterations which can also depend on patient age and chronicity of depression.</p>
<p id="par0230">The impaired glutamate homeostasis observed in MDD patients may be related to the reduced astrocytic packing density detected from post-mortem studies on MDD brain samples. Furthermore, reduced expression of GLAST and GLT-1 occur in anterior cingulate (<xref ref-type="bibr" rid="bib0190">Choudary et al., 2005</xref>), dorsolateral prefrontal (<xref ref-type="bibr" rid="bib0190">Choudary et al., 2005</xref>, <xref ref-type="bibr" rid="bib0555">Klempan et al., 2009</xref>) and orbitofrontal cortex (<xref ref-type="bibr" rid="bib0705">Miguel-Hidalgo et al., 2010</xref>), and in locus coeruleus (<xref ref-type="bibr" rid="bib0070">Bernard et al., 2011</xref>, <xref ref-type="bibr" rid="bib0170">Chandley et al., 2013</xref>) and hippocampus (<xref ref-type="bibr" rid="bib0685">Medina et al., 2016</xref>) of subjects diagnosed with MDD. Finally, different cortical and subcortical regions of depressed suicide victims, such as prefrontal and premotor cortex and the amygdala, also display reduced levels of GS (<xref ref-type="bibr" rid="bib0705">Miguel-Hidalgo et al., 2010</xref>, <xref ref-type="bibr" rid="bib1035">Sequeira et al., 2009</xref>). Interestingly, it has been shown that the impairment in glutamate-related gene expression is specific to astrocyte in MDD, since it does not occur in neurons of MDD brains (<xref ref-type="bibr" rid="bib0070">Bernard et al., 2011</xref>), thus underlying the astrocytic basis of MDD pathology.</p>
<p id="par0235">In MDD not only glutamate regulation is impaired, but also GABA homeostasis. Indeed, reduced GABA levels have been found in the dorsomedial/dorsal anterolateral prefrontal cortex (<xref ref-type="bibr" rid="bib0425">Hasler et al., 2007</xref>), and in the occipital cortex (<xref ref-type="bibr" rid="bib0980">Sanacora et al., 2004</xref>) of depressed but not remitted MDD patients (<xref ref-type="bibr" rid="bib0995">Schür et al., 2016</xref>). Furthermore, in the dorsolateral prefrontal cortex, GABA<sub>A</sub> receptor subunits are up-regulated (<xref ref-type="bibr" rid="bib0190">Choudary et al., 2005</xref>, <xref ref-type="bibr" rid="bib1035">Sequeira et al., 2009</xref>). Interestingly, it has been shown that α1 and β3 subunit expression is selectively increased in suicide completers (<xref ref-type="bibr" rid="bib0190">Choudary et al., 2005</xref>).</p>
</sec>
<sec id="sec0110">
<label>6.3</label>
<title>Membrane channels and proteins</title>
<p id="par0240">Several astrocytic-specific membrane channels have been demonstrated to be altered in MDD subjects. A decrease in gene and protein expression of Cx43 and Cx30 occurs in the dorsolateral prefrontal cortex of suicide completers (<xref ref-type="bibr" rid="bib0315">Ernst et al., 2011</xref>) and in the locus coeruleus of MDD patients (<xref ref-type="bibr" rid="bib0070">Bernard et al., 2011</xref>). Cx43 levels are also reduced in the orbitofrontal cortex (<xref ref-type="bibr" rid="bib0710">Miguel-Hidalgo et al., 2014</xref>) and hippocampus (<xref ref-type="bibr" rid="bib0685">Medina et al., 2016</xref>).</p>
<p id="par0245">Astrocytes in MDD subjects display altered K<sup>+</sup> and water homeostasis: Kir4.1 channels are down-regulated in the hippocampus of depressed patients (<xref ref-type="bibr" rid="bib0685">Medina et al., 2016</xref>); AQP4 immunoreactivity and mRNA levels decrease in the grey matter of orbitofrontal cortex, where the coverage of blood vessels by astrocytic endfeet is reduced (<xref ref-type="bibr" rid="bib0895">Rajkowska et al., 2013</xref>), in locus coeruleus and in the hippocampus of MDD patients, compared to psychiatrically-normal control subjects (<xref ref-type="bibr" rid="bib0070">Bernard et al., 2011</xref>, <xref ref-type="bibr" rid="bib0685">Medina et al., 2016</xref>).</p>
<p id="par0250">Finally, another astrocytic marker, the Ca<sup>2+</sup> binding protein S100β, which is predominantly expressed and secreted by grey matter astrocytes and involved in several Ca<sup>2+</sup>-dependent intracellular functions, is affected in MDD pathology. S100β mRNA levels are decreased in the prefrontal cortex and hippocampus of depressed suicide victims (<xref ref-type="bibr" rid="bib0070">Bernard et al., 2011</xref>, <xref ref-type="bibr" rid="bib0555">Klempan et al., 2009</xref>), and the number of S100β<sup>+</sup> astrocytes is strongly reduced in CA1 hippocampal region of MDD patients (<xref ref-type="bibr" rid="bib0375">Gos et al., 2013</xref>). Furthermore, in agreement with MDD astrocytic pathology, S100β cerebrospinal fluid and serum levels are increased (<xref ref-type="bibr" rid="bib0380">Grabe et al., 2001</xref>, <xref ref-type="bibr" rid="bib0955">Rothermundt et al., 2001</xref>, <xref ref-type="bibr" rid="bib1010">Schroeter et al., 2002</xref>, <xref ref-type="bibr" rid="bib1015">Schroeter et al., 2008</xref>), probably reflecting leakage of S100β from astrocytic cytoplasm into extracellular compartments.</p>
<p id="par0255">To summarize, key features of MDD include a reduction in astrocyte population and alterations in the expression of several astrocytic markers, such as GFAP, GJ proteins, AQP4, Kir4.1 channels, S100β and glutamate transporters. MDD patients do not present prominent astrogliosis, glial scar formation and neuronal degeneration, which are conversely observed in other brain disorders, such as tumours, AD, amyotrophic lateral sclerosis and Huntington’s disease. Astrocytes can thus be considered as novel targets for antidepressant medications. Nonetheless, the reciprocal communication between astrocytes and neurons in MDD remains still unclear; moreover, it would be interesting to determine whether alterations of astrocytic physiology and number are present only during episodes of depression or also during periods of remission.</p>
</sec>
</sec>
<sec id="sec0115">
<label>7</label>
<title>Down syndrome</title>
<p id="par0260">Down syndrome (DS) is the most common well-known chromosomal disorder, affecting one in every 700 babies in the United States (<xref ref-type="bibr" rid="bib0830">Parker et al., 2010</xref>). DS is caused by the trisomy of chromosome 21, and characterized by mental retardation, language impairment and other phenotypic abnormalities, such as slanting eyes, flat facial feature and hypotonia. Furthermore, in addition to developmental failure, DS is characterized by AD-like pathology, with neuritic Aβ plaques widely developing in the hippocampus and enthorinal cortex of almost all adults with DS and in some DS children (<xref ref-type="bibr" rid="bib0460">Hof et al., 1995</xref>, <xref ref-type="bibr" rid="bib0480">Hyman et al., 1995</xref>, <xref ref-type="bibr" rid="bib0620">Leverenz and Raskind, 1998</xref>). Directly related to mental retardation, a number of neuropathological changes found in DS CNS have been widely described, including reduced neuron number, alterations of cortical lamination, decreased dendritic ramifications and diminished synaptic spines, delayed myelination and reduce size of hemispheres (<xref ref-type="bibr" rid="bib0365">Golden and Hyman, 1994</xref>, <xref ref-type="bibr" rid="bib0945">Ross et al., 1984</xref>, <xref ref-type="bibr" rid="bib1220">Wisniewski, 1990</xref>). However, several studies indicate that astrocytes are also involved in DS, and display modifications of their number, structure and intracellular proteins (<xref ref-type="fig" rid="fig0010">Fig. 2</xref>f).</p>
<sec id="sec0120">
<label>7.1</label>
<title>Astrocytic over-population and structure</title>
<p id="par0265">Despite the reduced number of neurons, which is due to severely impaired proliferation and increased apoptosis (<xref ref-type="bibr" rid="bib0215">Contestabile et al., 2007</xref>), DS brains present an altered number of glial cells, especially astrocytes. In particular, DS foetuses between 17 and 21 weeks of gestation have a higher percentage of cells with astrocytic phenotype and a smaller percentage of cells with neuronal phenotype in the hippocampus (<xref ref-type="bibr" rid="bib0395">Guidi et al., 2008</xref>), thus indicating a shift from neurogenesis to gliogenesis. Similar results were also found in the DS frontal lobe, where astrocytes were more numerous and morphologically more mature than those of age-matched controls (<xref ref-type="bibr" rid="bib1265">Zdaniuk et al., 2011</xref>). Furthermore, a two-fold developmental bias toward astrocyte differentiation in DS neural cultures (<xref ref-type="bibr" rid="bib0125">Briggs et al., 2013</xref>), which occurs through the release of astrocytic S100β (<xref ref-type="bibr" rid="bib0180">Chen et al., 2014</xref>), was reported using DS-induced pluripotent stem cells obtained by episomal reprogramming.</p>
<p id="par0270">Astrocytes in DS are not only more proliferative and abundant, but they also display altered processes. DS brains display an impaired development of interlaminar astrocytes, which starts normally around 20–40 days after birth, but manifests a breakdown by the first year of age. This results in decreased number of interlaminar processes and immature astroglial layout, which can occur in several brain regions with different gravity (<xref ref-type="bibr" rid="bib0205">Colombo et al., 2005</xref>). Moreover, decreased GFAP mRNA levels have been found in the superior prefrontal cortex of DS subjects and in temporal lobe white matter of DS foetuses during middle pregnancy period (<xref ref-type="bibr" rid="bib0370">Goodison et al., 1993</xref>, <xref ref-type="bibr" rid="bib0525">Kanaumi et al., 2013</xref>). Similar results have also been obtained in the frontal lobe white matter of older patients. Interestingly, the pattern was reversed in the cortex, where an increase in GFAP<sup>+</sup> cell number was observed, probably reflecting premature dementia-associated development of plaques and neurofibrillary tangles (<xref ref-type="bibr" rid="bib0490">Jørgensen et al., 1990</xref>, <xref ref-type="bibr" rid="bib0730">Mito and Becker, 1993</xref>).</p>
</sec>
<sec id="sec0125">
<label>7.2</label>
<title>Glutamate and Ca<sup>2+</sup> signalling</title>
<p id="par0275">Contradictory observations have been reported regarding the level of glutamate in DS: some post-mortem studies found no difference in glutamate or glutamine concentrations in the frontal lobes of foetal DS brains (<xref ref-type="bibr" rid="bib1190">Whittle et al., 2007</xref>), while others reported decreased levels in the hippocampus or unchanged levels in temporal and frontal lobe of adult DS subjects (<xref ref-type="bibr" rid="bib0910">Reynolds and Warner, 1988</xref>, <xref ref-type="bibr" rid="bib0925">Risser et al., 1997</xref>, <xref ref-type="bibr" rid="bib1025">Seidl et al., 2001</xref>). A more recent study found no significant difference in hippocampal glutamate-glutamine levels between adult DS subjects and controls (<xref ref-type="bibr" rid="bib1100">Tan et al., 2014</xref>), using <italic>in vivo</italic> proton magnetic resonance spectroscopy to overcome the limitations deriving from post-mortem analysis of neurotransmitters. This suggests that glutamate levels do not account for the cognitive impairment in DS.</p>
<p id="par0280">However, an alteration in mGluR5 expression has been identified in patients with DS. White matter astrocytes of DS hippocampus display an increased prenatal mGluR5 expression, which persists post-natally. Furthermore, in adult DS patients with diffuse AD-associated neurodegeneration, higher levels of mGluR5 are also detected in astrocytes close to amyloid plaques (<xref ref-type="bibr" rid="bib0485">Iyer et al., 2014</xref>). The altered mGluR5 expression in astrocytes, which can affect intracellular Ca<sup>2+</sup> signalling, is accompanied by augmented levels of S100β, as S100β protein exhibits a persistent over-expression in the hippocampus and in temporal, frontal and occipital lobes of DS foetuses, infants, children and adults (<xref ref-type="bibr" rid="bib0390">Griffin et al., 1998</xref>, <xref ref-type="bibr" rid="bib0385">Griffin et al., 1989</xref>, <xref ref-type="bibr" rid="bib0490">Jørgensen et al., 1990</xref>, <xref ref-type="bibr" rid="bib0730">Mito and Becker, 1993</xref>). Elevated levels of S100β mRNA have also been documented in the superior prefrontal cortex of adult DS brains (<xref ref-type="bibr" rid="bib0370">Goodison et al., 1993</xref>). Interestingly, a significant positive correlation has been found between S100β expression and patient age or cortical Aβ deposition, and the number of S100β-overexpressing activated astrocytes also strongly correlate with Aβ plaque density (<xref ref-type="bibr" rid="bib0970">Royston et al., 1999</xref>), thus suggesting a contribution of S100β overexpression to plaque formation and progression in DS.</p>
<p id="par0285">The cognitive impairment observed in DS patients has been mainly attributed to defective neurogenesis and reduction in the number of neurons in several brain regions. However, the increased number of astrocytes found in DS brains, together with the altered morphology and the impaired expression of glutamate and Ca<sup>2+</sup>-signalling related proteins, suggest that a dysfunction of astrocytes may be a potential factor leading to DS intellectual disability.</p>
</sec>
</sec>
<sec id="sec0130">
<label>8</label>
<title>Conclusions</title>
<p id="par0290">During the last decades, the neurocentric view of the CNS has left the place to a multifaceted and more integrated paradigm of looking at and studying the brain. Nowadays, not only neurons but also other cell types and their reciprocal interactions are considered in explaining physiological CNS functions and dysfunctions. Human astrocytes display an intimate and dynamic structural-functional relationship with neurons, which makes them capable of regulating brain homeostasis and functioning. In the light of these physiological tasks, it is to be predicted that astrocytes can be implicated in cerebral pathology. Indeed, alterations of glial cells and neuroglial interactions have been widely described in animal models of various neurological diseases. Glial morphological and functional changes have been identified in post-mortem or surgically resected human brain tissue from patients with different brain disorders. In this review, we report evidence of astrocytic changes in the human brain in epilepsy, brain tumours, AD, MDD and DS. Prominent astrogliosis is a hallmark of epilepsy, brain tumours and AD. Remarkably, in these pathologies astrogliosis is associated with a decreased expression of astrocytic K<sup>+</sup> channels and glutamate transporters, which leads to accumulation of K<sup>+</sup> and glutamate in the extracellular space. MDD and DS instead show reduced extracellular glutamate levels and do not display reactive astrogliosis. In addition, a reduced number of astrocytes is observed in MDD, while an enhanced proliferation but impaired development of astrocytic populations occurs in DS.</p>
<p id="par0295">Investigations conducted on human brain samples are particularly important to study the alterations leading to disease development and progression, since animal models are far from reproducing all the peculiarities of human pathologies. However, both the quantity of specimen and tissue are limited; furthermore, the access to proper control tissue is problematic, human testing being ethically inappropriate. Nonetheless, the study of human-specific changes in brain disorders becomes necessary to confirm findings obtained with animal studies and proceed towards the discovery of new therapeutic strategies; indeed, anatomo-pathological alterations do not always correlate with the clinical symptoms of the disease and animals do not develop the high cognitive functions which are specific of humans and that are lost during the progression of CNS diseases.</p>
<p id="par0300">Targeting astrocytes thus represent an attractive alternative approach to develop new therapies to treat neurological disorders in humans. It has already been shown that targeting ephrin-A5, a molecule which is expressed by reactive astrocytes in the <italic>peri</italic>-infarct region, improves recovery after stroke in mice (<xref ref-type="bibr" rid="bib0815">Overman et al., 2012</xref>), and that currently used antidepressant drugs act by rescuing astrocytic defects, such as <sc>d</sc>-serine decrease (<xref ref-type="bibr" rid="bib0660">Malkesman et al., 2012</xref>). Moreover, there is evidence suggesting that a limitation of TNFα signalling specifically in astrocytes could be beneficial in autism spectrum disorders (<xref ref-type="bibr" rid="bib0795">Okabe et al., 2012</xref>, <xref ref-type="bibr" rid="bib0845">Petrelli et al., 2016</xref>, <xref ref-type="bibr" rid="bib1250">Yasui et al., 2013</xref>) and that some β-lactam antibiotics can increase GLT-1 expression and delay amyotrophic lateral sclerosis progression in animals (<xref ref-type="bibr" rid="bib0960">Rothstein et al., 2005</xref>). New therapeutic strategies based on transplantation of astrocytes or their progenitors are also promising, as indicated by the improved outcome observed in a mouse model of motor neuron disease (<xref ref-type="bibr" rid="bib0615">Lepore et al., 2008</xref>).</p>
<p id="par0305">However, it is essential to better clarify which astrocytic alterations are pathologically relevant in different brain regions and whether disease-related glial changes are causative or simply an accompanying phenomenon. This will help build a more integrated picture of brain pathologies, which could result in novel effective therapeutic strategies targeting human astrocytes and their interactions with neighbouring neurons.</p>
</sec>
<sec id="sec0135">
<title>Conflict of interest statement</title>
<p id="par0310">The authors declare that there are no conflicts of interest.</p>
</sec>
</body>
<back>
<ref-list id="bibl0005">
<title>References</title>
<ref id="bib0005">
<element-citation id="sbref0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akbarpour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sayyah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Babapour</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mahdian</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Beheshti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kamyab</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Expression of connexin 30 and connexin 32 in hippocampus of rat during epileptogenesis in a kindling model of epilepsy</article-title>
<source/>Neurosci. Bull.
          <volume>28</volume>
<year>2012</year>
<fpage>729</fpage>
<lpage>736</lpage>
<pub-id pub-id-type="pmid">23149765</pub-id>
</element-citation>
</ref>
<ref id="bib0010">
<element-citation id="sbref0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Saido</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>P.L.</given-names>
</name>
</person-group>
<article-title>Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer’s disease</article-title>
<source/>Glia
          <volume>25</volume>
<year>1999</year>
<fpage>324</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="pmid">10028915</pub-id>
</element-citation>
</ref>
<ref id="bib0015">
<element-citation id="sbref0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altamura</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression</article-title>
<source/>Eur. Neuropsychopharmacol.
          <volume>5</volume>
<issue>Suppl</issue>
<year>1995</year>
<fpage>71</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">8775762</pub-id>
</element-citation>
</ref>
<ref id="bib0020">
<element-citation id="sbref0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altshuler</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Abulseoud</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Foland-Ross</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bartzokis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mintz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hellemann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
</person-group>
<article-title>Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder</article-title>
<source/>Bipolar Disord.
          <volume>12</volume>
<year>2010</year>
<fpage>541</fpage>
<lpage>549</lpage>
<pub-id pub-id-type="pmid">20712756</pub-id>
</element-citation>
</ref>
<ref id="bib0025">
<element-citation id="sbref0025" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>American Psychiatric Association</surname>
</name>
</person-group>
<chapter-title>Diagnostic and Statistical Manual of Mental Disorders</chapter-title>
<edition>5th edition</edition>
<year>2013</year>
<publisher-name>American Psychiatric Association</publisher-name>
<comment>ISBN-13: 9780890425558</comment>
</element-citation>
</ref>
<ref id="bib0030">
<element-citation id="sbref0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Ao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sofroniew</surname>
<given-names>M.V.</given-names>
</name>
</person-group>
<article-title>Heterogeneity of reactive astrocytes</article-title>
<source/>Neurosci. Lett.
          <volume>565</volume>
<year>2014</year>
<fpage>23</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">24361547</pub-id>
</element-citation>
</ref>
<ref id="bib0035">
<element-citation id="sbref0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araque</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Carmignoto</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haydon</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Oliet</surname>
<given-names>S.H.R.</given-names>
</name>
<name>
<surname>Robitaille</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Volterra</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Gliotransmitters travel in time and space</article-title>
<source/>Neuron
          <volume>81</volume>
<year>2014</year>
<fpage>728</fpage>
<lpage>739</lpage>
<pub-id pub-id-type="pmid">24559669</pub-id>
</element-citation>
</ref>
<ref id="bib0040">
<element-citation id="sbref0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gorter</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>G.H.</given-names>
</name>
<name>
<surname>Leenstra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yankaya</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>101</volume>
<year>2001</year>
<fpage>449</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="pmid">11484816</pub-id>
</element-citation>
</ref>
<ref id="bib0045">
<element-citation id="sbref0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auer</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Pütz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lipinski</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study</article-title>
<source/>Biol. Psychiatry
          <volume>47</volume>
<year>2000</year>
<fpage>305</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">10686265</pub-id>
</element-citation>
</ref>
<ref id="bib0050">
<element-citation id="sbref0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bazargani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Attwell</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Astrocyte calcium signaling: the third wave</article-title>
<source/>Nat. Neurosci.
          <volume>19</volume>
<year>2016</year>
<fpage>182</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">26814587</pub-id>
</element-citation>
</ref>
<ref id="bib0055">
<element-citation id="sbref0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beach</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>E.G.</given-names>
</name>
</person-group>
<article-title>Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer’s disease visual cortex</article-title>
<source/>Brain Res.
          <volume>463</volume>
<year>1988</year>
<fpage>357</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">3196922</pub-id>
</element-citation>
</ref>
<ref id="bib0060">
<element-citation id="sbref0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beckstrøm</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Julsrud</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Haugeto</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dewar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Lehre</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer’s disease</article-title>
<source/>J. Neurosci. Res.
          <volume>55</volume>
<year>1999</year>
<fpage>218</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">9972824</pub-id>
</element-citation>
</ref>
<ref id="bib0065">
<element-citation id="sbref0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dupper</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hüttmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Herde</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Dublin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schramm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Häussler</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Henneberger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Theis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Steinhäuser</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Astrocyte uncoupling as a cause of human temporal lobe epilepsy</article-title>
<source/>Brain J. Neurol.
          <year>2015</year>
</element-citation>
</ref>
<ref id="bib0070">
<element-citation id="sbref0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kerman</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Barchas</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression</article-title>
<source/>Mol. Psychiatry
          <volume>16</volume>
<year>2011</year>
<fpage>634</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="pmid">20386568</pub-id>
</element-citation>
</ref>
<ref id="bib0075">
<element-citation id="sbref0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjørnsen</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Holmseth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures</article-title>
<source/>Neurobiol. Dis.
          <volume>25</volume>
<year>2007</year>
<fpage>319</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">17112731</pub-id>
</element-citation>
</ref>
<ref id="bib0080">
<element-citation id="sbref0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Newcombe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waxman</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5</article-title>
<source/>Brain J. Neurol.
          <volume>133</volume>
<year>2010</year>
<fpage>835</fpage>
<lpage>846</lpage>
</element-citation>
</ref>
<ref id="bib0085">
<element-citation id="sbref0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bockenhauer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Feather</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stanescu</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Bandulik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zdebik</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Reichold</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tobin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lieberer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sterner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Landoure</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arora</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sirimanna</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>van’t Hoff</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Al Masri</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tullus</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Anikster</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Klootwijk</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hubank</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dillon</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Heitzmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Arcos-Burgos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Knepper</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Dobbie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gahl</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Warth</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kleta</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations</article-title>
<source/>N. Engl. J. Med.
          <volume>360</volume>
<year>2009</year>
<fpage>1960</fpage>
<lpage>1970</lpage>
<pub-id pub-id-type="pmid">19420365</pub-id>
</element-citation>
</ref>
<ref id="bib0090">
<element-citation id="sbref0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bordey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Electrophysiological properties of human astrocytic tumor cells in situ: enigma of spiking glial cells</article-title>
<source/>J. Neurophysiol.
          <volume>79</volume>
<year>1998</year>
<fpage>2782</fpage>
<lpage>2793</lpage>
<pub-id pub-id-type="pmid">9582244</pub-id>
</element-citation>
</ref>
<ref id="bib0095">
<element-citation id="sbref0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bordey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Distinct electrophysiological alterations in dentate gyrus versus CA1 glial cells from epileptic humans with temporal lobe sclerosis</article-title>
<source/>Epilepsy Res.
          <volume>59</volume>
<year>2004</year>
<fpage>107</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">15246115</pub-id>
</element-citation>
</ref>
<ref id="bib0100">
<element-citation id="sbref0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouvier</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Quesseveur</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Davoli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>A Ferreira</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Quirion</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Murai</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>High resolution dissection of reactive glial nets in Alzheimer’s disease</article-title>
<source/>Sci. Rep.
          <volume>6</volume>
<year>2016</year>
<fpage>24544</fpage>
<pub-id pub-id-type="pmid">27090093</pub-id>
</element-citation>
</ref>
<ref id="bib0105">
<element-citation id="sbref0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowley</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Drevets</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Ongür</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Low glial numbers in the amygdala in major depressive disorder</article-title>
<source/>Biol. Psychiatry
          <volume>52</volume>
<year>2002</year>
<fpage>404</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="pmid">12242056</pub-id>
</element-citation>
</ref>
<ref id="bib0110">
<element-citation id="sbref0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Neuropathological stageing of Alzheimer-related changes</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>82</volume>
<year>1991</year>
<fpage>239</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="pmid">1759558</pub-id>
</element-citation>
</ref>
<ref id="bib0115">
<element-citation id="sbref0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Staging of Alzheimer’s disease-related neurofibrillary changes</article-title>
<source/>Neurobiol. Aging
          <volume>16</volume>
<year>1995</year>
<comment>(271–278-284)</comment>
</element-citation>
</ref>
<ref id="bib0120">
<element-citation id="sbref0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brenner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Boespflug-Tanguy</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Messing</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease</article-title>
<source/>Nat. Genet.
          <volume>27</volume>
<year>2001</year>
<fpage>117</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">11138011</pub-id>
</element-citation>
</ref>
<ref id="bib0125">
<element-citation id="sbref0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briggs</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ovchinnikov</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>T.-L.</given-names>
</name>
<name>
<surname>Nayler</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>L.-P.</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Thakar</surname>
<given-names>N.Y.</given-names>
</name>
<name>
<surname>Soo</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Peura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grimmond</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wolvetang</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology</article-title>
<source/>Stem Cells Dayt. Ohio
          <volume>31</volume>
<year>2013</year>
<fpage>467</fpage>
<lpage>478</lpage>
</element-citation>
</ref>
<ref id="bib0130">
<element-citation id="sbref0130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronen</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Sze</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Imaging findings in hippocampal sclerosis: correlation with pathology</article-title>
<source/>Am. J. Neuroradiol.
          <volume>12</volume>
<year>1991</year>
<fpage>933</fpage>
<lpage>940</lpage>
<pub-id pub-id-type="pmid">1950925</pub-id>
</element-citation>
</ref>
<ref id="bib0135">
<element-citation id="sbref0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buono</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Lohoff</surname>
<given-names>F.W.</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sperling</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dlugos</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Scattergood</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Berrettini</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>T.N.</given-names>
</name>
</person-group>
<article-title>Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility</article-title>
<source/>Epilepsy Res.
          <volume>58</volume>
<year>2004</year>
<fpage>175</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="pmid">15120748</pub-id>
</element-citation>
</ref>
<ref id="bib0140">
<element-citation id="sbref0140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burel-Vandenbos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Benchetrit</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miquel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fontaine</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Auvergne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lebrun-Frenay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cardot-Leccia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Michiels</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Paquis-Flucklinger</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Virolle</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis</article-title>
<source/>J. Neurooncol.
          <volume>102</volume>
<year>2011</year>
<fpage>171</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">20652725</pub-id>
</element-citation>
</ref>
<ref id="bib0145">
<element-citation id="sbref0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butt</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kalsi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions</article-title>
<source/>J. Cell. Mol. Med.
          <volume>10</volume>
<year>2006</year>
<fpage>33</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="pmid">16563220</pub-id>
</element-citation>
</ref>
<ref id="bib0150">
<element-citation id="sbref0150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caltabiano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Torrisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Condorelli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lanzafame</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>High levels of connexin 43 mRNA in high grade astrocytomas. Study of 32 cases with in situ hybridization</article-title>
<source/>Acta Histochem.
          <volume>112</volume>
<year>2010</year>
<fpage>529</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="pmid">19604543</pub-id>
</element-citation>
</ref>
<ref id="bib0155">
<element-citation id="sbref0155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavus</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kasoff</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Cassaday</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gueorguieva</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sherwin</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Krystal</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Abi-Saab</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Extracellular metabolites in the cortex and hippocampus of epileptic patients</article-title>
<source/>Ann. Neurol.
          <volume>57</volume>
<year>2005</year>
<fpage>226</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="pmid">15668975</pub-id>
</element-citation>
</ref>
<ref id="bib0160">
<element-citation id="sbref0160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavus</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Hetherington</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Abi-Saab</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zaveri</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Krystal</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients</article-title>
<source/>Epilepsia
          <volume>49</volume>
<year>2008</year>
<fpage>1358</fpage>
<lpage>1366</lpage>
<pub-id pub-id-type="pmid">18410365</pub-id>
</element-citation>
</ref>
<ref id="bib0165">
<element-citation id="sbref0165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beasley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>I.P.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density</article-title>
<source/>Biol. Psychiatry
          <volume>53</volume>
<year>2003</year>
<fpage>1086</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="pmid">12814860</pub-id>
</element-citation>
</ref>
<ref id="bib0170">
<element-citation id="sbref0170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandley</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Szebeni</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Szebeni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Ordway</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder</article-title>
<source/>J. Psychiatry Neurosci.
          <volume>38</volume>
<year>2013</year>
<fpage>276</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">23415275</pub-id>
</element-citation>
</ref>
<ref id="bib0175">
<element-citation id="sbref0175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Astrocytes and brain injury</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <volume>23</volume>
<year>2003</year>
<fpage>137</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">12571445</pub-id>
</element-citation>
</ref>
<ref id="bib0180">
<element-citation id="sbref0180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>McCann</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Parast</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pleasure</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Laurent</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Loring</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells</article-title>
<source/>Nat. Commun.
          <volume>5</volume>
<year>2014</year>
<fpage>4430</fpage>
<pub-id pub-id-type="pmid">25034944</pub-id>
</element-citation>
</ref>
<ref id="bib0185">
<element-citation id="sbref0185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chever</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Djukic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Amzica</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Implication of Kir4.1 channel in excess potassium clearance: an in vivo study on anesthetized glial-conditional Kir4.1 knock-out mice</article-title>
<source/>J. Neurosci.
          <volume>30</volume>
<year>2010</year>
<fpage>15769</fpage>
<lpage>15777</lpage>
<pub-id pub-id-type="pmid">21106816</pub-id>
</element-citation>
</ref>
<ref id="bib0190">
<element-citation id="sbref0190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudary</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Molnar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.Z.</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E.G.</given-names>
</name>
</person-group>
<article-title>Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>102</volume>
<year>2005</year>
<fpage>15653</fpage>
<lpage>15658</lpage>
<pub-id pub-id-type="pmid">16230605</pub-id>
</element-citation>
</ref>
<ref id="bib0195">
<element-citation id="sbref0195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cobb</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Overholser</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Jurjus</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Dieter</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Herbst</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Hippocampal volume and total cell numbers in major depressive disorder</article-title>
<source/>J. Psychiatr. Res.
          <volume>47</volume>
<year>2013</year>
<fpage>299</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">23201228</pub-id>
</element-citation>
</ref>
<ref id="bib0200">
<element-citation id="sbref0200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collignon</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wetjen</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Cohen-Gadol</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Cascino</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Parisi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Weigand</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans</article-title>
<source/>J. Neurosurg.
          <volume>105</volume>
<year>2006</year>
<fpage>77</fpage>
<lpage>87</lpage>
</element-citation>
</ref>
<ref id="bib0205">
<element-citation id="sbref0205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colombo</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Reisin</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bentham</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Development of interlaminar astroglial processes in the cerebral cortex of control and Down’s syndrome human cases</article-title>
<source/>Exp. Neurol.
          <volume>193</volume>
<year>2005</year>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="pmid">15817279</pub-id>
</element-citation>
</ref>
<ref id="bib0210">
<element-citation id="sbref0210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Condorelli</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Mudò</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trovato-Salinaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mirone</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Belluardo</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Connexin-30 mRNA is up-regulated in astrocytes and expressed in apoptotic neuronal cells of rat brain following kainate-induced seizures</article-title>
<source/>Mol. Cell. Neurosci.
          <volume>21</volume>
<year>2002</year>
<fpage>94</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="pmid">12359154</pub-id>
</element-citation>
</ref>
<ref id="bib0215">
<element-citation id="sbref0215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Contestabile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fila</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ceccarelli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bonasoni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bonapace</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bartesaghi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ciani</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice</article-title>
<source/>Hippocampus
          <volume>17</volume>
<year>2007</year>
<fpage>665</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="pmid">17546680</pub-id>
</element-citation>
</ref>
<ref id="bib0220">
<element-citation id="sbref0220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosgrove</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fitzgibbons</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Sherrod</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chandrasoma</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Intermediate filament expression in astrocytic neoplasms</article-title>
<source/>Am. J. Surg. Pathol.
          <volume>13</volume>
<year>1989</year>
<fpage>141</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">2464954</pub-id>
</element-citation>
</ref>
<ref id="bib0225">
<element-citation id="sbref0225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kerwin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder</article-title>
<source/>Arch. Gen. Psychiatry
          <volume>58</volume>
<year>2001</year>
<fpage>545</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="pmid">11386983</pub-id>
</element-citation>
</ref>
<ref id="bib0230">
<element-citation id="sbref0230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Beasley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>I.P.</given-names>
</name>
</person-group>
<article-title>Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder</article-title>
<source/>Cereb. Cortex
          <volume>1991</volume>
<issue>12</issue>
<year>2002</year>
<fpage>386</fpage>
<lpage>394</lpage>
</element-citation>
</ref>
<ref id="bib0235">
<element-citation id="sbref0235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia</article-title>
<source/>Bipolar Disord.
          <volume>7</volume>
<year>2005</year>
<fpage>358</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="pmid">16026489</pub-id>
</element-citation>
</ref>
<ref id="bib0240">
<element-citation id="sbref0240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coulter</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Astrocytic regulation of glutamate homeostasis in epilepsy</article-title>
<source/>Glia
          <volume>60</volume>
<year>2012</year>
<fpage>1215</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="pmid">22592998</pub-id>
</element-citation>
</ref>
<ref id="bib0245">
<element-citation id="sbref0245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crunelli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cope</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Terry</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Transition to absence seizures and the role of GABA(A) receptors</article-title>
<source/>Epilepsy Res.
          <volume>97</volume>
<year>2011</year>
<fpage>283</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="pmid">21889315</pub-id>
</element-citation>
</ref>
<ref id="bib0250">
<element-citation id="sbref0250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dallérac</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rouach</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Astrocytes as new targets to improve cognitive functions</article-title>
<source/>Prog. Neurobiol.
          <year>2016</year>
</element-citation>
</ref>
<ref id="bib0255">
<element-citation id="sbref0255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McDowell</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Bonilha</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Glazier</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Banik</surname>
<given-names>N.L.</given-names>
</name>
</person-group>
<article-title>Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors</article-title>
<source/>Neuroscience
          <volume>220</volume>
<year>2012</year>
<fpage>237</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">22698689</pub-id>
</element-citation>
</ref>
<ref id="bib0260">
<element-citation id="sbref0260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalaria</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <volume>73</volume>
<year>2002</year>
<fpage>556</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="pmid">12397151</pub-id>
</element-citation>
</ref>
<ref id="bib0265">
<element-citation id="sbref0265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Groot</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>W.K.A.</given-names>
</name>
</person-group>
<article-title>The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo</article-title>
<source/>Cancer Res.
          <volume>65</volume>
<year>2005</year>
<fpage>1934</fpage>
<lpage>1940</lpage>
<pub-id pub-id-type="pmid">15753393</pub-id>
</element-citation>
</ref>
<ref id="bib0270">
<element-citation id="sbref0270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeWitt</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Doller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer’s disease</article-title>
<source/>Exp. Neurol.
          <volume>149</volume>
<year>1998</year>
<fpage>329</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">9500964</pub-id>
</element-citation>
</ref>
<ref id="bib0275">
<element-citation id="sbref0275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djamshidian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grassl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seltenhammer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Czech</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schmidbauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zimprich</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Altered expression of voltage-dependent calcium channel alpha(1) subunits in temporal lobe epilepsy with Ammon’s horn sclerosis</article-title>
<source/>Neuroscience
          <volume>111</volume>
<year>2002</year>
<fpage>57</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">11955712</pub-id>
</element-citation>
</ref>
<ref id="bib0280">
<element-citation id="sbref0280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djukic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Casper</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Philpot</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>L.-S.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>K.D.</given-names>
</name>
</person-group>
<article-title>Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation</article-title>
<source/>J. Neurosci.
          <volume>27</volume>
<year>2007</year>
<fpage>11354</fpage>
<lpage>11365</lpage>
<pub-id pub-id-type="pmid">17942730</pub-id>
</element-citation>
</ref>
<ref id="bib0285">
<element-citation id="sbref0285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>During</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain</article-title>
<source/>Lancet Lond. Engl.
          <volume>341</volume>
<year>1993</year>
<fpage>1607</fpage>
<lpage>1610</lpage>
</element-citation>
</ref>
<ref id="bib0290">
<element-citation id="sbref0290" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eddleston</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mucke</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Molecular profile of reactive astrocytes–implications for their role in neurologic disease</article-title>
<source/>Neuroscience
          <volume>54</volume>
<year>1993</year>
<fpage>15</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">8515840</pub-id>
</element-citation>
</ref>
<ref id="bib0295">
<element-citation id="sbref0295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Rundén-Pran</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>J.C.K.</given-names>
</name>
<name>
<surname>Malthankar</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy</article-title>
<source/>Lancet Lond. Engl.
          <volume>363</volume>
<year>2004</year>
<fpage>28</fpage>
<lpage>37</lpage>
</element-citation>
</ref>
<ref id="bib0300">
<element-citation id="sbref0300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.-S.W.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Amiry-Moghaddam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bjørnsen</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>102</volume>
<year>2005</year>
<fpage>1193</fpage>
<lpage>1198</lpage>
<pub-id pub-id-type="pmid">15657133</pub-id>
</element-citation>
</ref>
<ref id="bib0305">
<element-citation id="sbref0305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Behar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dhaher</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bumanglag</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.-S.W.</given-names>
</name>
</person-group>
<article-title>Roles of glutamine synthetase inhibition in epilepsy</article-title>
<source/>Neurochem. Res.
          <volume>37</volume>
<year>2012</year>
<fpage>2339</fpage>
<lpage>2350</lpage>
<pub-id pub-id-type="pmid">22488332</pub-id>
</element-citation>
</ref>
<ref id="bib0310">
<element-citation id="sbref0310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elisevich</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rempel</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Edvardsen</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Hippocampal connexin 43 expression in human complex partial seizure disorder</article-title>
<source/>Exp. Neurol.
          <volume>145</volume>
<year>1997</year>
<fpage>154</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="pmid">9184118</pub-id>
</element-citation>
</ref>
<ref id="bib0315">
<element-citation id="sbref0315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hellstrom</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Gershenfeld</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers</article-title>
<source/>Biol. Psychiatry
          <volume>70</volume>
<year>2011</year>
<fpage>312</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="pmid">21571253</pub-id>
</element-citation>
</ref>
<ref id="bib0320">
<element-citation id="sbref0320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahrner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Flubacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Freiman</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Zentner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Frotscher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients</article-title>
<source/>Exp. Neurol.
          <volume>203</volume>
<year>2007</year>
<fpage>320</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="pmid">17049346</pub-id>
</element-citation>
</ref>
<ref id="bib0325">
<element-citation id="sbref0325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Laurence</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Araghi-Niknam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stary</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gottesman</surname>
<given-names>I.I.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia</article-title>
<source/>Schizophr. Res.
          <volume>69</volume>
<year>2004</year>
<fpage>317</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">15469203</pub-id>
</element-citation>
</ref>
<ref id="bib0330">
<element-citation id="sbref0330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>L.F.B.</given-names>
</name>
</person-group>
<article-title>Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy</article-title>
<source/>Brain Res.
          <volume>929</volume>
<year>2002</year>
<fpage>105</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">11852037</pub-id>
</element-citation>
</ref>
<ref id="bib0335">
<element-citation id="sbref0335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saido</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yokofujita</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Okeda</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ihara</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain</article-title>
<source/>Am. J. Pathol.
          <volume>152</volume>
<year>1998</year>
<fpage>983</fpage>
<lpage>992</lpage>
<pub-id pub-id-type="pmid">9546359</pub-id>
</element-citation>
</ref>
<ref id="bib0340">
<element-citation id="sbref0340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furnari</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Fenton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bachoo</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Mukasa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stommel</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Stegh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Ligon</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>DePinho</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Cavenee</surname>
<given-names>W.K.</given-names>
</name>
</person-group>
<article-title>Malignant astrocytic glioma: genetics, biology, and paths to treatment</article-title>
<source/>Genes Dev.
          <volume>21</volume>
<year>2007</year>
<fpage>2683</fpage>
<lpage>2710</lpage>
<pub-id pub-id-type="pmid">17974913</pub-id>
</element-citation>
</ref>
<ref id="bib0345">
<element-citation id="sbref0345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gómez-Gonzalo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin-Fernandez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martínez-Murillo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mederos</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hernández-Vivanco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jamison</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calero</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Futch</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Corpas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sanfeliu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Perea</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Araque</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neuron-astrocyte signaling is preserved in the aging brain</article-title>
<source/>Glia
          <year>2017</year>
</element-citation>
</ref>
<ref id="bib0350">
<element-citation id="sbref0350" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabriel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kivi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Lanksch</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Meencke</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Effects of barium on stimulus-induced changes in [K+]o and field potentials in dentate gyrus and area CA1 of human epileptic hippocampus</article-title>
<source/>Neurosci. Lett.
          <volume>249</volume>
<year>1998</year>
<fpage>91</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">9682824</pub-id>
</element-citation>
</ref>
<ref id="bib0355">
<element-citation id="sbref0355" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gadea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schinelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway</article-title>
<source/>J. Neurosci.
          <volume>28</volume>
<year>2008</year>
<fpage>2394</fpage>
<lpage>2408</lpage>
<pub-id pub-id-type="pmid">18322086</pub-id>
</element-citation>
</ref>
<ref id="bib0360">
<element-citation id="sbref0360" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gittins</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder</article-title>
<source/>J. Affect. Disord.
          <volume>133</volume>
<year>2011</year>
<fpage>328</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="pmid">21497910</pub-id>
</element-citation>
</ref>
<ref id="bib0365">
<element-citation id="sbref0365" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Development of the superior temporal neocortex is anomalous in trisomy 21</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>53</volume>
<year>1994</year>
<fpage>513</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">8083693</pub-id>
</element-citation>
</ref>
<ref id="bib0370">
<element-citation id="sbref0370" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodison</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Parhad</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Sima</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>A.W.</given-names>
</name>
</person-group>
<article-title>Neuronal and glial gene expression in neocortex of Down’s syndrome and Alzheimer’s disease</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>52</volume>
<year>1993</year>
<fpage>192</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">8492138</pub-id>
</element-citation>
</ref>
<ref id="bib0375">
<element-citation id="sbref0375" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gos</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schroeter</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Lessel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Dobrowolny</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schiltz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bogerts</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study</article-title>
<source/>J. Psychiatr. Res.
          <volume>47</volume>
<year>2013</year>
<fpage>1694</fpage>
<lpage>1699</lpage>
<pub-id pub-id-type="pmid">23896207</pub-id>
</element-citation>
</ref>
<ref id="bib0380">
<element-citation id="sbref0380" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabe</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Ahrens</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Freyberger</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Neurotrophic factor S100 beta in major depression</article-title>
<source/>Neuropsychobiology
          <volume>44</volume>
<year>2001</year>
<fpage>88</fpage>
<lpage>90</lpage>
<comment>54922</comment>
<pub-id pub-id-type="pmid">11490177</pub-id>
</element-citation>
</ref>
<ref id="bib0385">
<element-citation id="sbref0385" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>MacLeod</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Perrot</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Araoz</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>86</volume>
<year>1989</year>
<fpage>7611</fpage>
<lpage>7615</lpage>
<pub-id pub-id-type="pmid">2529544</pub-id>
</element-citation>
</ref>
<ref id="bib0390">
<element-citation id="sbref0390" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Royston</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Gentleman</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Brumback</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Cork</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Del Bigio</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Life-long overexpression of S100beta in Down’s syndrome: implications for Alzheimer pathogenesis</article-title>
<source/>Neurobiol. Aging
          <volume>19</volume>
<year>1998</year>
<fpage>401</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">9880042</pub-id>
</element-citation>
</ref>
<ref id="bib0395">
<element-citation id="sbref0395" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bonasoni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ceccarelli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gualtieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ciani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bartesaghi</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome</article-title>
<source/>Brain Pathol. Zurich Switz.
          <volume>18</volume>
<year>2008</year>
<fpage>180</fpage>
<lpage>197</lpage>
</element-citation>
</ref>
<ref id="bib0400">
<element-citation id="sbref0400" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Häberle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Görg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rutsch</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toutain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benoist</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Gelot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suc</surname>
<given-names>A.-L.</given-names>
</name>
<name>
<surname>Höhne</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schliess</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Häussinger</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>H.G.</given-names>
</name>
</person-group>
<article-title>Congenital glutamine deficiency with glutamine synthetase mutations</article-title>
<source/>N. Engl. J. Med.
          <volume>353</volume>
<year>2005</year>
<fpage>1926</fpage>
<lpage>1933</lpage>
<pub-id pub-id-type="pmid">16267323</pub-id>
</element-citation>
</ref>
<ref id="bib0405">
<element-citation id="sbref0405" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Häberle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shahbeck</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Ben-Omran</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Natural course of glutamine synthetase deficiency in a 3 year old patient</article-title>
<source/>Mol. Genet. Metab.
          <volume>103</volume>
<year>2011</year>
<fpage>89</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">21353613</pub-id>
</element-citation>
</ref>
<ref id="bib0410">
<element-citation id="sbref0410" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Murai</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses</article-title>
<source/>J. Neurosci.
          <volume>26</volume>
<year>2006</year>
<fpage>8881</fpage>
<lpage>8891</lpage>
<pub-id pub-id-type="pmid">16943543</pub-id>
</element-citation>
</ref>
<ref id="bib0415">
<element-citation id="sbref0415" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halassa</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Fellin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Haydon</surname>
<given-names>P.G.</given-names>
</name>
</person-group>
<article-title>The tripartite synapse: roles for gliotransmission in health and disease</article-title>
<source/>Trends Mol. Med.
          <volume>13</volume>
<year>2007</year>
<fpage>54</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">17207662</pub-id>
</element-citation>
</ref>
<ref id="bib0420">
<element-citation id="sbref0420" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iyo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Increased levels of glutamate in brains from patients with mood disorders</article-title>
<source/>Biol. Psychiatry
          <volume>62</volume>
<year>2007</year>
<fpage>1310</fpage>
<lpage>1316</lpage>
<pub-id pub-id-type="pmid">17574216</pub-id>
</element-citation>
</ref>
<ref id="bib0425">
<element-citation id="sbref0425" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>van der Veen</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Tumonis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Drevets</surname>
<given-names>W.C.</given-names>
</name>
</person-group>
<article-title>Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy</article-title>
<source/>Arch. Gen. Psychiatry
          <volume>64</volume>
<year>2007</year>
<fpage>193</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="pmid">17283286</pub-id>
</element-citation>
</ref>
<ref id="bib0430">
<element-citation id="sbref0430" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Lux</surname>
<given-names>H.D.</given-names>
</name>
</person-group>
<article-title>Ceiling of stimulus induced rises in extracellular potassium concentration in the cerebral cortex of cat</article-title>
<source/>Brain Res.
          <volume>120</volume>
<year>1977</year>
<fpage>231</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">832122</pub-id>
</element-citation>
</ref>
<ref id="bib0435">
<element-citation id="sbref0435" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jauch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kivi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eilers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>T.N.</given-names>
</name>
</person-group>
<article-title>Alterations of glial cell function in temporal lobe epilepsy</article-title>
<source/>Epilepsia
          <volume>41</volume>
<issue>Suppl. 6</issue>
<year>2000</year>
<fpage>S185</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">10999542</pub-id>
</element-citation>
</ref>
<ref id="bib0440">
<element-citation id="sbref0440" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herpers</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ramaekers</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Aldeweireldt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moesker</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Slooff</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>70</volume>
<year>1986</year>
<fpage>333</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="pmid">3020864</pub-id>
</element-citation>
</ref>
<ref id="bib0445">
<element-citation id="sbref0445" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heuser</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nagelhus</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Taubøll</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Indahl</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakken</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gjerstad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
</person-group>
<article-title>Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy</article-title>
<source/>Epilepsy Res.
          <volume>88</volume>
<year>2010</year>
<fpage>55</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="pmid">19864112</pub-id>
</element-citation>
</ref>
<ref id="bib0450">
<element-citation id="sbref0450" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heuser</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lauritzen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Thoren</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Vindedal</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Taubøll</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gjerstad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Nagelhus</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>71</volume>
<year>2012</year>
<fpage>814</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="pmid">22878665</pub-id>
</element-citation>
</ref>
<ref id="bib0455">
<element-citation id="sbref0455" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinterkeuser</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>SchroÈder</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hager</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>BluÈmcke</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Elger</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Schramm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>SteinhaÈuser</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances</article-title>
<source/>Eur. J. Neurosci.
          <volume>12</volume>
<year>2000</year>
<fpage>2087</fpage>
<lpage>2096</lpage>
<pub-id pub-id-type="pmid">10886348</pub-id>
</element-citation>
</ref>
<ref id="bib0460">
<element-citation id="sbref0460" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hof</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Bouras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Perl</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Sparks</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down’s syndrome. Quantitative regional analysis and comparison with Alzheimer’s disease</article-title>
<source/>Arch. Neurol.
          <volume>52</volume>
<year>1995</year>
<fpage>379</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="pmid">7710374</pub-id>
</element-citation>
</ref>
<ref id="bib0465">
<element-citation id="sbref0465" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Pekny</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system</article-title>
<source/>Curr. Opin. Cell Biol.
          <volume>32</volume>
<year>2015</year>
<fpage>121</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="pmid">25726916</pub-id>
</element-citation>
</ref>
<ref id="bib0470">
<element-citation id="sbref0470" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ugawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kakita</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>71</volume>
<year>2012</year>
<fpage>750</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="pmid">22805778</pub-id>
</element-citation>
</ref>
<ref id="bib0475">
<element-citation id="sbref0475" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hugg</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Kuzniecky</surname>
<given-names>R.I.</given-names>
</name>
</person-group>
<article-title>Diffusion mapping applied to mesial temporal lobe epilepsy: preliminary observations</article-title>
<source/>Neurology
          <volume>53</volume>
<year>1999</year>
<fpage>173</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">10408555</pub-id>
</element-citation>
</ref>
<ref id="bib0480">
<element-citation id="sbref0480" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Rebeck</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Neuropathological changes in Down’s syndrome hippocampal formation: effect of age and apolipoprotein E genotype</article-title>
<source/>Arch. Neurol.
          <volume>52</volume>
<year>1995</year>
<fpage>373</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="pmid">7710373</pub-id>
</element-citation>
</ref>
<ref id="bib0485">
<element-citation id="sbref0485" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>van Scheppingen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Milenkovic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Anink</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Genazzani</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Adle-Biassette</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Metabotropic glutamate receptor 5 in Down’s syndrome hippocampus during development: increased expression in astrocytes</article-title>
<source/>Curr. Alzheimer Res.
          <volume>11</volume>
<year>2014</year>
<fpage>694</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="pmid">25115540</pub-id>
</element-citation>
</ref>
<ref id="bib0490">
<element-citation id="sbref0490" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jørgensen</surname>
<given-names>O.S.</given-names>
</name>
<name>
<surname>Brooksbank</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Balázs</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease</article-title>
<source/>J. Neurol. Sci.
          <volume>98</volume>
<year>1990</year>
<fpage>63</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">1977892</pub-id>
</element-citation>
</ref>
<ref id="bib0495">
<element-citation id="sbref0495" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacob</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Koutsilieri</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bartl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neuen-Jacob</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arzberger</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zander</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ravid</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Roggendorf</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Riederer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grünblatt</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer’s disease</article-title>
<source/>J. Alzheimers Dis.
          <volume>11</volume>
<year>2007</year>
<fpage>97</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">17361039</pub-id>
</element-citation>
</ref>
<ref id="bib0500">
<element-citation id="sbref0500" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jauch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Windmüller</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>T.-N.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effects of barium, furosemide, ouabaine and 4, 4′-diisothiocyanatostilbene-2, 2′-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy</article-title>
<source/>Brain Res.
          <volume>925</volume>
<year>2002</year>
<fpage>18</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">11755897</pub-id>
</element-citation>
</ref>
<ref id="bib0505">
<element-citation id="sbref0505" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jesse</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Steinacker</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cepek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>von Arnim</surname>
<given-names>C.A.F.</given-names>
</name>
<name>
<surname>Tumani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lehnert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Baier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Otto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer’s disease and Creutzfeldt-Jakob disease</article-title>
<source/>J. Alzheimers Dis.
          <volume>17</volume>
<year>2009</year>
<fpage>541</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="pmid">19433893</pub-id>
</element-citation>
</ref>
<ref id="bib0510">
<element-citation id="sbref0510" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yarishkin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>Y.E.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>B.-E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kowall</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease</article-title>
<source/>Nat. Med.
          <volume>20</volume>
<year>2014</year>
<fpage>886</fpage>
<lpage>896</lpage>
<pub-id pub-id-type="pmid">24973918</pub-id>
</element-citation>
</ref>
<ref id="bib0515">
<element-citation id="sbref0515" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston-Wilson</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shore</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Torrey</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium</article-title>
<source/>Mol. Psychiatry
          <volume>5</volume>
<year>2000</year>
<fpage>142</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">10822341</pub-id>
</element-citation>
</ref>
<ref id="bib0520">
<element-citation id="sbref0520" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamphuis</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Middeldorp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kooijman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sluijs</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Kooi</surname>
<given-names>E.-J.</given-names>
</name>
<name>
<surname>Moeton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Freriks</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizee</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <volume>35</volume>
<year>2014</year>
<fpage>492</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="pmid">24269023</pub-id>
</element-citation>
</ref>
<ref id="bib0525">
<element-citation id="sbref0525" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanaumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Milenkovic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Adle-Biassette</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>G.G.</given-names>
</name>
</person-group>
<article-title>Non-neuronal cell responses differ between normal and Down syndrome developing brains</article-title>
<source/>Int. J. Dev. Neurosci.
          <volume>31</volume>
<year>2013</year>
<fpage>796</fpage>
<lpage>803</lpage>
<pub-id pub-id-type="pmid">24113258</pub-id>
</element-citation>
</ref>
<ref id="bib0530">
<element-citation id="sbref0530" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashon</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>O’Callaghan</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Petrovitch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Burchfiel</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Hardman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>L.R.</given-names>
</name>
</person-group>
<article-title>Associations of cortical astrogliosis with cognitive performance and dementia status</article-title>
<source/>J. Alzheimers Dis.
          <volume>6</volume>
<year>2004</year>
<comment>595–604–681</comment>
</element-citation>
</ref>
<ref id="bib0535">
<element-citation id="sbref0535" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hoshii</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Confocal observation of senile plaques in Alzheimer’s disease: senile plaque morphology and relationship between senile plaques and astrocytes</article-title>
<source/>Pathol. Int.
          <volume>48</volume>
<year>1998</year>
<fpage>332</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">9704339</pub-id>
</element-citation>
</ref>
<ref id="bib0540">
<element-citation id="sbref0540" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khundakar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>A morphometric examination of neuronal and glial cell pathology in the orbitofrontal cortex in late-life depression</article-title>
<source/>Int. Psychogeriatr.
          <volume>23</volume>
<year>2011</year>
<fpage>132</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">20561380</pub-id>
</element-citation>
</ref>
<ref id="bib0545">
<element-citation id="sbref0545" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khundakar</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Oakley</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Cellular pathology within the anterior cingulate cortex of patients with late-life depression: a morphometric study</article-title>
<source/>Psychiatry Res.
          <volume>194</volume>
<year>2011</year>
<fpage>184</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">21924875</pub-id>
</element-citation>
</ref>
<ref id="bib0550">
<element-citation id="sbref0550" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kivi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Kovács</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eilers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jauch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Meencke</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>von Deimling</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1</article-title>
<source/>Eur. J. Neurosci.
          <volume>12</volume>
<year>2000</year>
<fpage>2039</fpage>
<lpage>2048</lpage>
<pub-id pub-id-type="pmid">10886343</pub-id>
</element-citation>
</ref>
<ref id="bib0555">
<element-citation id="sbref0555" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klempan</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Sequeira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Canetti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lalovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>ffrench-Mullen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression</article-title>
<source/>Mol. Psychiatry
          <volume>14</volume>
<year>2009</year>
<fpage>175</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">17938633</pub-id>
</element-citation>
</ref>
<ref id="bib0560">
<element-citation id="sbref0560" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koulakoff</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Orellana</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Sáez</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Giaume</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Glial connexin expression and function in the context of Alzheimer’s disease</article-title>
<source/>Biochim. Biophys. Acta
          <volume>1818</volume>
<year>2012</year>
<fpage>2048</fpage>
<lpage>2057</lpage>
<pub-id pub-id-type="pmid">22008509</pub-id>
</element-citation>
</ref>
<ref id="bib0565">
<element-citation id="sbref0565" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuchibhotla</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Lattarulo</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Bacskai</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice</article-title>
<source/>Science
          <volume>323</volume>
<year>2009</year>
<fpage>1211</fpage>
<lpage>1215</lpage>
<pub-id pub-id-type="pmid">19251629</pub-id>
</element-citation>
</ref>
<ref id="bib0570">
<element-citation id="sbref0570" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurt</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>beta-Amyloid immunoreactivity in astrocytes in Alzheimer’s disease brain biopsies: an electron microscope study</article-title>
<source/>Exp. Neurol.
          <volume>158</volume>
<year>1999</year>
<fpage>221</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="pmid">10448435</pub-id>
</element-citation>
</ref>
<ref id="bib0575">
<element-citation id="sbref0575" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurzwelly</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Herrlinger</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Seizures in patients with low-grade gliomas–incidence, pathogenesis, surgical management, and pharmacotherapy</article-title>
<source/>Adv. Tech. Stand. Neurosurg.
          <volume>35</volume>
<year>2010</year>
<fpage>81</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">20102112</pub-id>
</element-citation>
</ref>
<ref id="bib0580">
<element-citation id="sbref0580" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasagna-Reeves</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kayed</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Astrocytes contain amyloid-β annular protofibrils in Alzheimer’s disease brains</article-title>
<source/>FEBS Lett.
          <volume>585</volume>
<year>2011</year>
<fpage>3052</fpage>
<lpage>3057</lpage>
<pub-id pub-id-type="pmid">21872592</pub-id>
</element-citation>
</ref>
<ref id="bib0585">
<element-citation id="sbref0585" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Prince</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Delaere</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fages</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lefrançois</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Touret</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salanon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tardy</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type</article-title>
<source/>Neurochem. Res.
          <volume>20</volume>
<year>1995</year>
<fpage>859</fpage>
<lpage>862</lpage>
<pub-id pub-id-type="pmid">7477679</pub-id>
</element-citation>
</ref>
<ref id="bib0590">
<element-citation id="sbref0590" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Magge</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cornell-Bell</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Human epileptic astrocytes exhibit increased gap junction coupling</article-title>
<source/>Glia
          <volume>15</volume>
<year>1995</year>
<fpage>195</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="pmid">8567071</pub-id>
</element-citation>
</ref>
<ref id="bib0595">
<element-citation id="sbref0595" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>108</volume>
<year>2004</year>
<fpage>493</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">15517312</pub-id>
</element-citation>
</ref>
<ref id="bib0600">
<element-citation id="sbref0600" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.-S.</given-names>
</name>
<name>
<surname>Bjørnsen</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>111</volume>
<year>2006</year>
<fpage>351</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="pmid">16456667</pub-id>
</element-citation>
</ref>
<ref id="bib0605">
<element-citation id="sbref0605" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Borboa</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eliceiri</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title>Non-invasive quantification of brain tumor-induced astrogliosis</article-title>
<source/>BMC Neurosci.
          <volume>12</volume>
<year>2011</year>
<fpage>9</fpage>
<comment>10.1186/1471-2202-12-9</comment>
<pub-id pub-id-type="pmid">21247490</pub-id>
</element-citation>
</ref>
<ref id="bib0610">
<element-citation id="sbref0610" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>P.L.</given-names>
</name>
</person-group>
<article-title>Mechanisms of GABA release from human astrocytes</article-title>
<source/>Glia
          <volume>59</volume>
<year>2011</year>
<fpage>1600</fpage>
<lpage>1611</lpage>
<pub-id pub-id-type="pmid">21748804</pub-id>
</element-citation>
</ref>
<ref id="bib0615">
<element-citation id="sbref0615" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepore</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Rauck</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dejea</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Maragakis</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease</article-title>
<source/>Nat. Neurosci.
          <volume>11</volume>
<year>2008</year>
<fpage>1294</fpage>
<lpage>1301</lpage>
<pub-id pub-id-type="pmid">18931666</pub-id>
</element-citation>
</ref>
<ref id="bib0620">
<element-citation id="sbref0620" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leverenz</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Raskind</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis</article-title>
<source/>Exp. Neurol.
          <volume>150</volume>
<year>1998</year>
<fpage>296</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="pmid">9527899</pub-id>
</element-citation>
</ref>
<ref id="bib0625">
<element-citation id="sbref0625" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levison</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Stoltzfus</surname>
<given-names>O.K.</given-names>
</name>
<name>
<surname>Ducceschi</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation</article-title>
<source/>Glia
          <volume>32</volume>
<year>2000</year>
<fpage>328</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="pmid">11102972</pub-id>
</element-citation>
</ref>
<ref id="bib0630">
<element-citation id="sbref0630" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mallory</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>56</volume>
<year>1997</year>
<fpage>901</fpage>
<lpage>911</lpage>
<pub-id pub-id-type="pmid">9258260</pub-id>
</element-citation>
</ref>
<ref id="bib0635">
<element-citation id="sbref0635" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ronco</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Grolla</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Canonico</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Genazzani</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB</article-title>
<source/>Glia
          <volume>61</volume>
<year>2013</year>
<fpage>1134</fpage>
<lpage>1145</lpage>
<pub-id pub-id-type="pmid">23616440</pub-id>
</element-citation>
</ref>
<ref id="bib0640">
<element-citation id="sbref0640" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Ohgaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wiestler</surname>
<given-names>O.D.</given-names>
</name>
<name>
<surname>Cavenee</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Jouvet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scheithauer</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Kleihues</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The 2007 WHO classification of tumours of the central nervous system</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>114</volume>
<year>2007</year>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">17618441</pub-id>
</element-citation>
</ref>
<ref id="bib0645">
<element-citation id="sbref0645" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynam</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Drazkowski</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Sirven</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Noe</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Wilkens</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review</article-title>
<source/>Clin. Neurol. Neurosurg.
          <volume>109</volume>
<year>2007</year>
<fpage>634</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="pmid">17601658</pub-id>
</element-citation>
</ref>
<ref id="bib0650">
<element-citation id="sbref0650" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyons</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Ogunrinu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Autocrine glutamate signaling promotes glioma cell invasion</article-title>
<source/>Cancer Res.
          <volume>67</volume>
<year>2007</year>
<fpage>9463</fpage>
<lpage>9471</lpage>
<pub-id pub-id-type="pmid">17909056</pub-id>
</element-citation>
</ref>
<ref id="bib0655">
<element-citation id="sbref0655" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Müller</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Lucassen</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Yassouridis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoogendijk</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus</article-title>
<source/>Eur. J. Neurosci.
          <volume>14</volume>
<year>2001</year>
<fpage>1603</fpage>
<lpage>1612</lpage>
<pub-id pub-id-type="pmid">11860455</pub-id>
</element-citation>
</ref>
<ref id="bib0660">
<element-citation id="sbref0660" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malkesman</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Tragon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rompala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hamidi</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zarate</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Acute D-serine treatment produces antidepressant-like effects in rodents</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <volume>15</volume>
<year>2012</year>
<fpage>1135</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="pmid">21906419</pub-id>
</element-citation>
</ref>
<ref id="bib0665">
<element-citation id="sbref0665" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshak</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Increased S100 beta neurotrophic activity in Alzheimer’s disease temporal lobe</article-title>
<source/>Neurobiol. Aging
          <volume>13</volume>
<year>1992</year>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">1371849</pub-id>
</element-citation>
</ref>
<ref id="bib0670">
<element-citation id="sbref0670" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Middeldorp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Sisodiya</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Squier</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Thom</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies</article-title>
<source/>Neuropathol. Appl. Neurobiol.
          <volume>35</volume>
<year>2009</year>
<fpage>394</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">19508443</pub-id>
</element-citation>
</ref>
<ref id="bib0675">
<element-citation id="sbref0675" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathern</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lozada</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pretorius</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Dehnes</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Chimelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Born</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Assirati</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Fried</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Peacock</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Ojemann</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Adelson</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy</article-title>
<source/>Neurology
          <volume>52</volume>
<year>1999</year>
<fpage>453</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="pmid">10025773</pub-id>
</element-citation>
</ref>
<ref id="bib0680">
<element-citation id="sbref0680" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medici</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Frassoni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tassi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spreafico</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garbelli</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Aquaporin 4 expression in control and epileptic human cerebral cortex</article-title>
<source/>Brain Res.
          <volume>1367</volume>
<year>2011</year>
<fpage>330</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="pmid">20934410</pub-id>
</element-citation>
</ref>
<ref id="bib0685">
<element-citation id="sbref0685" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barchas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>Evidence for alterations of the glial syncytial function in major depressive disorder</article-title>
<source/>J. Psychiatr. Res.
          <volume>72</volume>
<year>2016</year>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">26519765</pub-id>
</element-citation>
</ref>
<ref id="bib0690">
<element-citation id="sbref0690" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Erfurth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ohrmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Heindel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pfleiderer</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression</article-title>
<source/>Neuropsychopharmacology
          <volume>28</volume>
<year>2003</year>
<fpage>720</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="pmid">12655317</pub-id>
</element-citation>
</ref>
<ref id="bib0695">
<element-citation id="sbref0695" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Middeldorp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van den Berge</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Speijer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer</article-title>
<source/>PLoS One
          <volume>4</volume>
<year>2009</year>
<fpage>e7663</fpage>
<pub-id pub-id-type="pmid">19888461</pub-id>
</element-citation>
</ref>
<ref id="bib0700">
<element-citation id="sbref0700" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Baucom</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dilley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Overholser</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder</article-title>
<source/>Biol. Psychiatry
          <volume>48</volume>
<year>2000</year>
<fpage>861</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="pmid">11063981</pub-id>
</element-citation>
</ref>
<ref id="bib0705">
<element-citation id="sbref0705" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Waltzer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Whittom</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Glial and glutamatergic markers in depression, alcoholism, and their comorbidity</article-title>
<source/>J. Affect. Disord.
          <volume>127</volume>
<year>2010</year>
<fpage>230</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="pmid">20580095</pub-id>
</element-citation>
</ref>
<ref id="bib0710">
<element-citation id="sbref0710" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meshram</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression</article-title>
<source/>J. Psychiatr. Res.
          <volume>55</volume>
<year>2014</year>
<fpage>101</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="pmid">24774648</pub-id>
</element-citation>
</ref>
<ref id="bib0715">
<element-citation id="sbref0715" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>107</volume>
<year>2010</year>
<fpage>12698</fpage>
<lpage>12703</lpage>
<pub-id pub-id-type="pmid">20616000</pub-id>
</element-citation>
</ref>
<ref id="bib0720">
<element-citation id="sbref0720" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirza</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ivey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression</article-title>
<source/>J. Am. Acad. Child Adolesc. Psychiatry
          <volume>43</volume>
<year>2004</year>
<fpage>341</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">15076268</pub-id>
</element-citation>
</ref>
<ref id="bib0725">
<element-citation id="sbref0725" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitew</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kirkcaldie</surname>
<given-names>M.T.K.</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Vickers</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Altered synapses and gliotransmission in Alzheimer’s disease and AD model mice</article-title>
<source/>Neurobiol. Aging
          <volume>34</volume>
<year>2013</year>
<fpage>2341</fpage>
<lpage>2351</lpage>
<pub-id pub-id-type="pmid">23643146</pub-id>
</element-citation>
</ref>
<ref id="bib0730">
<element-citation id="sbref0730" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>L.E.</given-names>
</name>
</person-group>
<article-title>Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome</article-title>
<source/>Exp. Neurol.
          <volume>120</volume>
<year>1993</year>
<fpage>170</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">8491278</pub-id>
</element-citation>
</ref>
<ref id="bib0735">
<element-citation id="sbref0735" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer’s disease</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>55</volume>
<year>1996</year>
<fpage>273</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">8786385</pub-id>
</element-citation>
</ref>
<ref id="bib0740">
<element-citation id="sbref0740" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Re</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chalazonitis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Wichterle</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Przedborski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons</article-title>
<source/>Nat. Neurosci.
          <volume>10</volume>
<year>2007</year>
<fpage>615</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="pmid">17435755</pub-id>
</element-citation>
</ref>
<ref id="bib0745">
<element-citation id="sbref0745" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagele</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>D’Andrea</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Venkataraman</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.-Y.</given-names>
</name>
</person-group>
<article-title>Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains</article-title>
<source/>Brain Res.
          <volume>971</volume>
<year>2003</year>
<fpage>197</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">12706236</pub-id>
</element-citation>
</ref>
<ref id="bib0750">
<element-citation id="sbref0750" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagele</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Wegiel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Venkataraman</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Imaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.-C.</given-names>
</name>
<name>
<surname>Wegiel</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <volume>25</volume>
<year>2004</year>
<fpage>663</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">15172746</pub-id>
</element-citation>
</ref>
<ref id="bib0755">
<element-citation id="sbref0755" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagelhus</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Mathiisen</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Ottersen</surname>
<given-names>O.P.</given-names>
</name>
</person-group>
<article-title>Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1</article-title>
<source/>Neuroscience
          <volume>129</volume>
<year>2004</year>
<fpage>905</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="pmid">15561407</pub-id>
</element-citation>
</ref>
<ref id="bib0760">
<element-citation id="sbref0760" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hertzberg</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Marotta</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer’s disease</article-title>
<source/>Brain Res.
          <volume>717</volume>
<year>1996</year>
<fpage>173</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">8738268</pub-id>
</element-citation>
</ref>
<ref id="bib0765">
<element-citation id="sbref0765" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naus</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Bechberger</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Gap junction gene expression in human seizure disorder</article-title>
<source/>Exp. Neurol.
          <volume>111</volume>
<year>1991</year>
<fpage>198</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="pmid">1846600</pub-id>
</element-citation>
</ref>
<ref id="bib0770">
<element-citation id="sbref0770" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarrete</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perea</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Maglio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Garcia de Sola</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Araque</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Astrocyte calcium signal and gliotransmission in human brain tissue</article-title>
<source/>Cereb. Cortex
          <volume>23</volume>
<year>2012</year>
<fpage>1240</fpage>
<lpage>1246</lpage>
<pub-id pub-id-type="pmid">22581850</pub-id>
</element-citation>
</ref>
<ref id="bib0775">
<element-citation id="sbref0775" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neary</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Trophic functions of nucleotides in the central nervous system</article-title>
<source/>Trends Neurosci.
          <volume>32</volume>
<year>2009</year>
<fpage>189</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="pmid">19282037</pub-id>
</element-citation>
</ref>
<ref id="bib0780">
<element-citation id="sbref0780" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Connor</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>de Lanerolle</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Astrocytes from human hippocampal epileptogenic foci exhibit action potential-like responses</article-title>
<source/>Epilepsia
          <volume>39</volume>
<year>1998</year>
<fpage>347</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="pmid">9578024</pub-id>
</element-citation>
</ref>
<ref id="bib0785">
<element-citation id="sbref0785" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oberheim</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Astrocytic complexity distinguishes the human brain</article-title>
<source/>Trends Neurosci.
          <volume>29</volume>
<year>2006</year>
<fpage>547</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="pmid">16938356</pub-id>
</element-citation>
</ref>
<ref id="bib0790">
<element-citation id="sbref0790" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oberheim</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.H.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Pilcher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ojemann</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Ransom</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Uniquely hominid features of adult human astrocytes</article-title>
<source/>J. Neurosci.
          <volume>29</volume>
<year>2009</year>
<fpage>3276</fpage>
<lpage>3287</lpage>
<pub-id pub-id-type="pmid">19279265</pub-id>
</element-citation>
</ref>
<ref id="bib0795">
<element-citation id="sbref0795" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okabe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mitsumasu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kosai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Matsuishi</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome</article-title>
<source/>PLoS One
          <volume>7</volume>
<year>2012</year>
<fpage>e35354</fpage>
<pub-id pub-id-type="pmid">22532851</pub-id>
</element-citation>
</ref>
<ref id="bib0800">
<element-citation id="sbref0800" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omori</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner</article-title>
<source/>Int. J. Cancer
          <volume>78</volume>
<year>1998</year>
<fpage>446</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="pmid">9797133</pub-id>
</element-citation>
</ref>
<ref id="bib0805">
<element-citation id="sbref0805" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ongür</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Drevets</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Glial reduction in the subgenual prefrontal cortex in mood disorders</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>95</volume>
<year>1998</year>
<fpage>13290</fpage>
<lpage>13295</lpage>
<pub-id pub-id-type="pmid">9789081</pub-id>
</element-citation>
</ref>
<ref id="bib0810">
<element-citation id="sbref0810" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orkand</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Kuffler</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Effect of nerve impulses on the membrane potential of glial cells in the central nervous system of amphibia</article-title>
<source/>J. Neurophysiol.
          <volume>29</volume>
<year>1966</year>
<fpage>788</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="pmid">5966435</pub-id>
</element-citation>
</ref>
<ref id="bib0815">
<element-citation id="sbref0815" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overman</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Clarkson</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Wanner</surname>
<given-names>I.B.</given-names>
</name>
<name>
<surname>Overman</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Eckstein</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Maguire</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Dinov</surname>
<given-names>I.D.</given-names>
</name>
<name>
<surname>Toga</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>109</volume>
<year>2012</year>
<fpage>E2230</fpage>
<lpage>E2239</lpage>
<pub-id pub-id-type="pmid">22837401</pub-id>
</element-citation>
</ref>
<ref id="bib0820">
<element-citation id="sbref0820" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pérez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barrachina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rodríguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Torrejón-Escribano</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Boada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hernández</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sánchez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease</article-title>
<source/>Brain Res.
          <volume>1128</volume>
<year>2007</year>
<fpage>164</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">17123487</pub-id>
</element-citation>
</ref>
<ref id="bib0825">
<element-citation id="sbref0825" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pallud</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Audureau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Blonski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bauchet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fontaine</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mandonnet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dezamis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Psimaras</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Guyotat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peruzzi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gal</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Parraga</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>M.-H.</given-names>
</name>
<name>
<surname>Vlaicu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Devaux</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duffau</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Taillandier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Capelle</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huberfeld</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Epileptic seizures in diffuse low-grade gliomas in adults</article-title>
<source/>Brain
          <year>2013</year>
</element-citation>
</ref>
<ref id="bib0830">
<element-citation id="sbref0830" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Canfield</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Rickard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>National Birth Defects Prevention Network</surname>
</name>
</person-group>
<article-title>Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006</article-title>
<source/>Birt. Defects Res. A. Clin. Mol. Teratol.
          <volume>88</volume>
<year>2010</year>
<fpage>1008</fpage>
<lpage>1016</lpage>
</element-citation>
</ref>
<ref id="bib0835">
<element-citation id="sbref0835" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Steenbeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hochstetter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huonker</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haueisen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haberland</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ebmeier</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hliscs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fiehler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nowak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kalff</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Source localization and possible causes of interictal epileptic activity in tumor-associated epilepsy</article-title>
<source/>Neurobiol. Dis.
          <volume>7</volume>
<year>2000</year>
<fpage>260</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">10964598</pub-id>
</element-citation>
</ref>
<ref id="bib0840">
<element-citation id="sbref0840" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paulson</surname>
<given-names>O.B.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>Does the release of potassium from astrocyte endfeet regulate cerebral blood flow?</article-title>
<source/>Science
          <volume>237</volume>
<year>1987</year>
<fpage>896</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="pmid">3616619</pub-id>
</element-citation>
</ref>
<ref id="bib0845">
<element-citation id="sbref0845" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pucci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bezzi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Astrocytes and microglia and their potential link with autism spectrum disorders</article-title>
<source/>Front. Cell. Neurosci.
          <volume>10</volume>
<year>2016</year>
<fpage>21</fpage>
<pub-id pub-id-type="pmid">26903806</pub-id>
</element-citation>
</ref>
<ref id="bib0850">
<element-citation id="sbref0850" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petroff</surname>
<given-names>O.A.C.</given-names>
</name>
<name>
<surname>Errante</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Glutamate-glutamine cycling in the epileptic human hippocampus</article-title>
<source/>Epilepsia
          <volume>43</volume>
<year>2002</year>
<fpage>703</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="pmid">12102672</pub-id>
</element-citation>
</ref>
<ref id="bib0855">
<element-citation id="sbref0855" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfleiderer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Erfurth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ohrmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hohmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wolgast</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fiebich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Heindel</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients</article-title>
<source/>Psychiatry Res.
          <volume>122</volume>
<year>2003</year>
<fpage>185</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">12694892</pub-id>
</element-citation>
</ref>
<ref id="bib0860">
<element-citation id="sbref0860" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pike</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Cotman</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Early association of reactive astrocytes with senile plaques in Alzheimer’s disease</article-title>
<source/>Exp. Neurol.
          <volume>132</volume>
<year>1995</year>
<fpage>172</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">7789457</pub-id>
</element-citation>
</ref>
<ref id="bib0865">
<element-citation id="sbref0865" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirttimaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parri</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Crunelli</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Astrocytic GABA transporter GAT-1 dysfunction in experimental absence seizures</article-title>
<source/>J. Physiol.
          <volume>591</volume>
<year>2013</year>
<fpage>823</fpage>
<lpage>833</lpage>
<pub-id pub-id-type="pmid">23090943</pub-id>
</element-citation>
</ref>
<ref id="bib0870">
<element-citation id="sbref0870" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proper</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Hoogland</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kappen</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>G.H.</given-names>
</name>
<name>
<surname>Rensen</surname>
<given-names>M.G.A.</given-names>
</name>
<name>
<surname>Schrama</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>van Veelen</surname>
<given-names>C.W.M.</given-names>
</name>
<name>
<surname>van Rijen</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>van Nieuwenhuizen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gispen</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>de Graan</surname>
<given-names>P.N.E.</given-names>
</name>
</person-group>
<article-title>Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy</article-title>
<source/>Brain J. Neurol.
          <volume>125</volume>
<year>2002</year>
<fpage>32</fpage>
<lpage>43</lpage>
</element-citation>
</ref>
<ref id="bib0875">
<element-citation id="sbref0875" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Altered expression of Cx43 in astrocytic tumors</article-title>
<source/>Clin. Neurol. Neurosurg.
          <volume>107</volume>
<year>2004</year>
<fpage>49</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">15567553</pub-id>
</element-citation>
</ref>
<ref id="bib0880">
<element-citation id="sbref0880" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Querfurth</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>LaFerla</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease</article-title>
<source/>N. Engl. J. Med.
          <volume>362</volume>
<year>2010</year>
<fpage>329</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">20107219</pub-id>
</element-citation>
</ref>
<ref id="bib0885">
<element-citation id="sbref0885" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dilley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Overholser</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression</article-title>
<source/>Biol. Psychiatry
          <volume>45</volume>
<year>1999</year>
<fpage>1085</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="pmid">10331101</pub-id>
</element-citation>
</ref>
<ref id="bib0890">
<element-citation id="sbref0890" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Dubey</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>K.R.R.</given-names>
</name>
</person-group>
<article-title>Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients</article-title>
<source/>Biol. Psychiatry
          <volume>58</volume>
<year>2005</year>
<fpage>297</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">15953590</pub-id>
</element-citation>
</ref>
<ref id="bib0895">
<element-citation id="sbref0895" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Javier Miguel-Hidalgo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maciag</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder</article-title>
<source/>Biol. Psychiatry
          <volume>73</volume>
<year>2013</year>
<fpage>613</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="pmid">23146357</pub-id>
</element-citation>
</ref>
<ref id="bib0900">
<element-citation id="sbref0900" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raore</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schniederjan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Brat</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>H.-K.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Metastasis infiltration: an investigation of the postoperative brain-tumor interface</article-title>
<source/>Int. J. Radiat. Oncol. Biol. Phys.
          <volume>81</volume>
<year>2011</year>
<fpage>1075</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="pmid">20971574</pub-id>
</element-citation>
</ref>
<ref id="bib0905">
<element-citation id="sbref0905" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichold</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zdebik</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Lieberer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rapedius</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bandulik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sterner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tegtmeier</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Penton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baukrowitz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hulton</surname>
<given-names>S.-A.</given-names>
</name>
<name>
<surname>Witzgall</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ben-Zeev</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Howie</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kleta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bockenhauer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Warth</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>107</volume>
<year>2010</year>
<fpage>14490</fpage>
<lpage>14495</lpage>
<pub-id pub-id-type="pmid">20651251</pub-id>
</element-citation>
</ref>
<ref id="bib0910">
<element-citation id="sbref0910" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynolds</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Amino acid neurotransmitter deficits in adult Down’s syndrome brain tissue</article-title>
<source/>Neurosci. Lett.
          <volume>94</volume>
<year>1988</year>
<fpage>224</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">2907377</pub-id>
</element-citation>
</ref>
<ref id="bib0915">
<element-citation id="sbref0915" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richerson</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore</article-title>
<source/>J. Neurophysiol.
          <volume>90</volume>
<year>2003</year>
<fpage>1363</fpage>
<lpage>1374</lpage>
<pub-id pub-id-type="pmid">12966170</pub-id>
</element-citation>
</ref>
<ref id="bib0920">
<element-citation id="sbref0920" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rijpkema</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schuuring</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van der Meulen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>van der Graaf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernsen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Boerman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van der Kogel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heerschap</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging</article-title>
<source/>NMR Biomed.
          <volume>16</volume>
<year>2003</year>
<fpage>12</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">12577293</pub-id>
</element-citation>
</ref>
<ref id="bib0925">
<element-citation id="sbref0925" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Risser</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lubec</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Herrera-Marschitz</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome</article-title>
<source/>Life Sci.
          <volume>60</volume>
<year>1997</year>
<fpage>1231</fpage>
<lpage>1237</lpage>
<pub-id pub-id-type="pmid">9096240</pub-id>
</element-citation>
</ref>
<ref id="bib0930">
<element-citation id="sbref0930" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robert</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Buckingham</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Robel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Ogunrinu-Babarinde</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Eschbacher</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Berens</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Lahti</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Nabors</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma</article-title>
<source/>Sci. Transl. Med.
          <volume>7</volume>
<year>2015</year>
<comment>289ra86</comment>
</element-citation>
</ref>
<ref id="bib0935">
<element-citation id="sbref0935" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodríguez-Arellano</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Parpura</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zorec</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Astrocytes in physiological aging and Alzheimer’s disease</article-title>
<source/>Neuroscience
          <volume>323</volume>
<year>2016</year>
<fpage>170</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">25595973</pub-id>
</element-citation>
</ref>
<ref id="bib0940">
<element-citation id="sbref0940" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roslin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Henriksson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bergström</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ungerstedt</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Bergenheim</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis</article-title>
<source/>J. Neurooncol.
          <volume>61</volume>
<year>2003</year>
<fpage>151</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="pmid">12622454</pub-id>
</element-citation>
</ref>
<ref id="bib0945">
<element-citation id="sbref0945" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Galaburda</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Down’s syndrome: is there a decreased population of neurons?</article-title>
<source/>Neurology
          <volume>34</volume>
<year>1984</year>
<fpage>909</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="pmid">6234479</pub-id>
</element-citation>
</ref>
<ref id="bib0950">
<element-citation id="sbref0950" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Volterra</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Astrocytic dysfunction: insights on the role in neurodegeneration</article-title>
<source/>Brain Res. Bull.
          <volume>80</volume>
<year>2009</year>
<fpage>224</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="pmid">19631259</pub-id>
</element-citation>
</ref>
<ref id="bib0955">
<element-citation id="sbref0955" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothermundt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Wiesmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Missler</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rudolf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kirchner</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>S-100B is increased in melancholic but not in non-melancholic major depression</article-title>
<source/>J. Affect. Disord.
          <volume>66</volume>
<year>2001</year>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">11532538</pub-id>
</element-citation>
</ref>
<ref id="bib0960">
<element-citation id="sbref0960" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothstein</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Haenggeli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Bergles</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dykes Hoberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vidensky</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Toan</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Bruijn</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z.-Z.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>P.B.</given-names>
</name>
</person-group>
<article-title>Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression</article-title>
<source/>Nature
          <volume>433</volume>
<year>2005</year>
<fpage>73</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">15635412</pub-id>
</element-citation>
</ref>
<ref id="bib0965">
<element-citation id="sbref0965" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rouach</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Koulakoff</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abudara</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Willecke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Giaume</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Astroglial metabolic networks sustain hippocampal synaptic transmission</article-title>
<source/>Science
          <volume>322</volume>
<year>2008</year>
<fpage>1551</fpage>
<lpage>1555</lpage>
<pub-id pub-id-type="pmid">19056987</pub-id>
</element-citation>
</ref>
<ref id="bib0970">
<element-citation id="sbref0970" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Royston</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Gentleman</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Overexpression of s100beta in Down’s syndrome: correlation with patient age and with beta-amyloid deposition</article-title>
<source/>Neuropathol. Appl. Neurobiol.
          <volume>25</volume>
<year>1999</year>
<fpage>387</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="pmid">10564528</pub-id>
</element-citation>
</ref>
<ref id="bib0975">
<element-citation id="sbref0975" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Söhl</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Güldenagel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Teubner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Traub</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gutiérrez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Willecke</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Expression of connexin genes in hippocampus of kainate-treated and kindled rats under conditions of experimental epilepsy</article-title>
<source/>Brain Res. Mol. Brain Res.
          <volume>83</volume>
<year>2000</year>
<fpage>44</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">11072094</pub-id>
</element-citation>
</ref>
<ref id="bib0980">
<element-citation id="sbref0980" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanacora</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gueorguieva</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Epperson</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.-T.</given-names>
</name>
<name>
<surname>Appel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Krystal</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>G.F.</given-names>
</name>
</person-group>
<article-title>Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression</article-title>
<source/>Arch. Gen. Psychiatry
          <volume>61</volume>
<year>2004</year>
<fpage>705</fpage>
<lpage>713</lpage>
<pub-id pub-id-type="pmid">15237082</pub-id>
</element-citation>
</ref>
<ref id="bib0985">
<element-citation id="sbref0985" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savaskan</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Heckel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hahnen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Engelhorn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Doerfler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ganslandt</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Nimsky</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Buchfelder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eyüpoglu</surname>
<given-names>I.Y.</given-names>
</name>
</person-group>
<article-title>Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema</article-title>
<source/>Nat. Med.
          <volume>14</volume>
<year>2008</year>
<fpage>629</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="pmid">18469825</pub-id>
</element-citation>
</ref>
<ref id="bib0990">
<element-citation id="sbref0990" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scarmeas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Honig</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cantero</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blacker</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amatniek</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Marder</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Seizures in Alzheimer disease: who, when, and how common?</article-title>
<source/>Arch. Neurol.
          <volume>66</volume>
<year>2009</year>
<fpage>992</fpage>
<lpage>997</lpage>
<pub-id pub-id-type="pmid">19667221</pub-id>
</element-citation>
</ref>
<ref id="bib0995">
<element-citation id="sbref0995" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schür</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Draisma</surname>
<given-names>L.W.R.</given-names>
</name>
<name>
<surname>Wijnen</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Boks</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Koevoets</surname>
<given-names>M.G.J.C.</given-names>
</name>
<name>
<surname>Joëls</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Klomp</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Vinkers</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies</article-title>
<source/>Hum. Brain Mapp.
          <volume>37</volume>
<year>2016</year>
<fpage>3337</fpage>
<lpage>3352</lpage>
<pub-id pub-id-type="pmid">27145016</pub-id>
</element-citation>
</ref>
<ref id="bib1000">
<element-citation id="sbref1000" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholl</surname>
<given-names>U.I.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ramaekers</surname>
<given-names>V.T.</given-names>
</name>
<name>
<surname>Häusler</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Grimmer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tobe</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Farhi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nelson-Williams</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lifton</surname>
<given-names>R.P.</given-names>
</name>
</person-group>
<article-title>Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>106</volume>
<year>2009</year>
<fpage>5842</fpage>
<lpage>5847</lpage>
<pub-id pub-id-type="pmid">19289823</pub-id>
</element-citation>
</ref>
<ref id="bib1005">
<element-citation id="sbref1005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schröder</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hinterkeuser</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schramm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jabs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wilkin</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Steinhäuser</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy</article-title>
<source/>Epilepsia
          <volume>41</volume>
<issue>Suppl. 6</issue>
<year>2000</year>
<fpage>S181</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">10999541</pub-id>
</element-citation>
</ref>
<ref id="bib1010">
<element-citation id="sbref1010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeter</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Abdul-Khaliq</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Diefenbacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blasig</surname>
<given-names>I.E.</given-names>
</name>
</person-group>
<article-title>S100B is increased in mood disorders and may be reduced by antidepressive treatment</article-title>
<source/>Neuroreport
          <volume>13</volume>
<year>2002</year>
<fpage>1675</fpage>
<lpage>1678</lpage>
<pub-id pub-id-type="pmid">12352625</pub-id>
</element-citation>
</ref>
<ref id="bib1015">
<element-citation id="sbref1015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeter</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Abdul-Khaliq</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Krebs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diefenbacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blasig</surname>
<given-names>I.E.</given-names>
</name>
</person-group>
<article-title>Serum markers support disease-specific glial pathology in major depression</article-title>
<source/>J. Affect. Disord.
          <volume>111</volume>
<year>2008</year>
<fpage>271</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="pmid">18430474</pub-id>
</element-citation>
</ref>
<ref id="bib1020">
<element-citation id="sbref1020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Gebhardt</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Mitrovic</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Vandenberg</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Glutamate transporter variants reduce glutamate uptake in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <volume>32</volume>
<year>2011</year>
<fpage>553</fpage>
<comment>e1-11</comment>
</element-citation>
</ref>
<ref id="bib1025">
<element-citation id="sbref1025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Singewald</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kaehler</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Lubec</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Differences between GABA levels in Alzheimer’s disease and Down syndrome with Alzheimer-like neuropathology</article-title>
<source/>Naunyn. Schmiedebergs Arch. Pharmacol.
          <volume>363</volume>
<year>2001</year>
<fpage>139</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="pmid">11218066</pub-id>
</element-citation>
</ref>
<ref id="bib1030">
<element-citation id="sbref1030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sendrowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sobaniec</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Hippocampus, hippocampal sclerosis and epilepsy</article-title>
<source/>Pharmacol. Rep.
          <volume>65</volume>
<year>2013</year>
<fpage>555</fpage>
<lpage>565</lpage>
<pub-id pub-id-type="pmid">23950578</pub-id>
</element-citation>
</ref>
<ref id="bib1035">
<element-citation id="sbref1035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mamdani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Bunney</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Lebel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rehal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Klempan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gratton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benkelfat</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression</article-title>
<source/>PLoS One
          <volume>4</volume>
<year>2009</year>
<fpage>e6585</fpage>
<pub-id pub-id-type="pmid">19668376</pub-id>
</element-citation>
</ref>
<ref id="bib1040">
<element-citation id="sbref1040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serrano-Pozo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gómez-Isla</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Growdon</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Frosch</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>A phenotypic change but not proliferation underlies glial responses in Alzheimer disease</article-title>
<source/>Am. J. Pathol.
          <volume>182</volume>
<year>2013</year>
<fpage>2332</fpage>
<lpage>2344</lpage>
<pub-id pub-id-type="pmid">23602650</pub-id>
</element-citation>
</ref>
<ref id="bib1045">
<element-citation id="sbref1045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques</article-title>
<source/>J. Neurosci. Res.
          <volume>39</volume>
<year>1994</year>
<fpage>398</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="pmid">7884819</pub-id>
</element-citation>
</ref>
<ref id="bib1050">
<element-citation id="sbref1050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Rovnaghi</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Kozlowska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Van Eldik</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <volume>17</volume>
<year>1996</year>
<fpage>359</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="pmid">8725896</pub-id>
</element-citation>
</ref>
<ref id="bib1055">
<element-citation id="sbref1055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Miguel-Hidalgo</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>O’Dwyer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression</article-title>
<source/>Neuropsychopharmacology
          <volume>29</volume>
<year>2004</year>
<fpage>2088</fpage>
<lpage>2096</lpage>
<pub-id pub-id-type="pmid">15238995</pub-id>
</element-citation>
</ref>
<ref id="bib1060">
<element-citation id="sbref1060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sicca</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Imbrici</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bonatti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brovedani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grottesi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guerrini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Masi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Santorelli</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Pessia</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1</article-title>
<source/>Neurobiol. Dis.
          <volume>43</volume>
<year>2011</year>
<fpage>239</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">21458570</pub-id>
</element-citation>
</ref>
<ref id="bib1065">
<element-citation id="sbref1065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Ince</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Lace</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Savva</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brayne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wharton</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>MRC Cognitive Function and Ageing Neuropathology Study Group</surname>
</name>
</person-group>
<article-title>Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain</article-title>
<source/>Neurobiol. Aging
          <volume>31</volume>
<year>2010</year>
<fpage>578</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">18586353</pub-id>
</element-citation>
</ref>
<ref id="bib1070">
<element-citation id="sbref1070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Ince</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Raman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garwood</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Gelsthorpe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Brayne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wharton</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>MRC Cognitive Function and Ageing Neuropathology Study Group</surname>
</name>
</person-group>
<article-title>Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer’s pathology and APOE genotype</article-title>
<source/>Neurobiol. Aging
          <volume>32</volume>
<year>2011</year>
<fpage>1795</fpage>
<lpage>1807</lpage>
<pub-id pub-id-type="pmid">21705112</pub-id>
</element-citation>
</ref>
<ref id="bib1075">
<element-citation id="sbref1075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
</person-group>
<article-title>Astrocytes: biology and pathology</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>119</volume>
<year>2010</year>
<fpage>7</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">20012068</pub-id>
</element-citation>
</ref>
<ref id="bib1080">
<element-citation id="sbref1080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofroniew</surname>
<given-names>M.V.</given-names>
</name>
</person-group>
<article-title>Molecular dissection of reactive astrogliosis and glial scar formation</article-title>
<source/>Trends Neurosci.
          <volume>32</volume>
<year>2009</year>
<fpage>638</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="pmid">19782411</pub-id>
</element-citation>
</ref>
<ref id="bib1085">
<element-citation id="sbref1085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soroceanu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Reduced expression of connexin-43 and functional gap junction coupling in human gliomas</article-title>
<source/>Glia
          <volume>33</volume>
<year>2001</year>
<fpage>107</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">11180508</pub-id>
</element-citation>
</ref>
<ref id="bib1090">
<element-citation id="sbref1090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stockmeier</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Konick</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Overholser</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Jurjus</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Uylings</surname>
<given-names>H.B.M.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Cellular changes in the postmortem hippocampus in major depression</article-title>
<source/>Biol. Psychiatry
          <volume>56</volume>
<year>2004</year>
<fpage>640</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="pmid">15522247</pub-id>
</element-citation>
</ref>
<ref id="bib1095">
<element-citation id="sbref1095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Wilcox</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Increased coupling and altered glutamate transport currents in astrocytes following kainic-acid-induced status epilepticus</article-title>
<source/>Neurobiol. Dis.
          <volume>40</volume>
<year>2010</year>
<fpage>573</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">20691786</pub-id>
</element-citation>
</ref>
<ref id="bib1100">
<element-citation id="sbref1100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Beacher</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Horder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Prasher</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hanney</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lovestone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy ((1)H MRS)</article-title>
<source/>J. Neurodev. Disord.
          <volume>6</volume>
<year>2014</year>
<fpage>42</fpage>
<pub-id pub-id-type="pmid">25937842</pub-id>
</element-citation>
</ref>
<ref id="bib1105">
<element-citation id="sbref1105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy</article-title>
<source/>J. Neurocytol.
          <volume>30</volume>
<year>2001</year>
<fpage>137</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">11577252</pub-id>
</element-citation>
</ref>
<ref id="bib1110">
<element-citation id="sbref1110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tessler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Danbolt</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Storm-Mathisen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Emson</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>Expression of the glutamate transporters in human temporal lobe epilepsy</article-title>
<source/>Neuroscience
          <volume>88</volume>
<year>1999</year>
<fpage>1083</fpage>
<lpage>1091</lpage>
<pub-id pub-id-type="pmid">10336123</pub-id>
</element-citation>
</ref>
<ref id="bib1115">
<element-citation id="sbref1115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thal</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Härtig</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schober</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Diffuse plaques in the molecular layer show intracellular A beta(8–17)-immunoreactive deposits in subpial astrocytes</article-title>
<source/>Clin. Neuropathol.
          <volume>18</volume>
<year>1999</year>
<fpage>226</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">10505431</pub-id>
</element-citation>
</ref>
<ref id="bib1120">
<element-citation id="sbref1120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thal</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dehghani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>100</volume>
<year>2000</year>
<fpage>608</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="pmid">11078212</pub-id>
</element-citation>
</ref>
<ref id="bib1125">
<element-citation id="sbref1125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thom</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Review: hippocampal sclerosis in epilepsy: a neuropathology review</article-title>
<source/>Neuropathol. Appl. Neurobiol.
          <volume>40</volume>
<year>2014</year>
<fpage>520</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="pmid">24762203</pub-id>
</element-citation>
</ref>
<ref id="bib1130">
<element-citation id="sbref1130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>G.-F.</given-names>
</name>
<name>
<surname>Azmi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oberheim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zielke</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nedergaard</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>An astrocytic basis of epilepsy</article-title>
<source/>Nat. Med.
          <volume>11</volume>
<year>2005</year>
<fpage>973</fpage>
<lpage>981</lpage>
<pub-id pub-id-type="pmid">16116433</pub-id>
</element-citation>
</ref>
<ref id="bib1135">
<element-citation id="sbref1135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ray-Chaudhury</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer’s disease</article-title>
<source/>J. Neurochem.
          <volume>113</volume>
<year>2010</year>
<fpage>978</fpage>
<lpage>989</lpage>
<pub-id pub-id-type="pmid">20193040</pub-id>
</element-citation>
</ref>
<ref id="bib1140">
<element-citation id="sbref1140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmer</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Herbert</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Claassen</surname>
<given-names>J.A.H.R.</given-names>
</name>
<name>
<surname>Kuiperij</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Verbeek</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer’s disease patients are unchanged</article-title>
<source/>Neurobiol. Aging
          <volume>36</volume>
<year>2015</year>
<fpage>1271</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="pmid">25577411</pub-id>
</element-citation>
</ref>
<ref id="bib1145">
<element-citation id="sbref1145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres-Platas</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Hercher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Davoli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Maussion</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Labonté</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides</article-title>
<source/>Neuropsychopharmacology
          <volume>36</volume>
<year>2011</year>
<fpage>2650</fpage>
<lpage>2658</lpage>
<pub-id pub-id-type="pmid">21814185</pub-id>
</element-citation>
</ref>
<ref id="bib1150">
<element-citation id="sbref1150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Hel</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Notenboom</surname>
<given-names>R.G.E.</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>I.W.M.</given-names>
</name>
<name>
<surname>van Rijen</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>van Veelen</surname>
<given-names>C.W.M.</given-names>
</name>
<name>
<surname>de Graan</surname>
<given-names>P.N.E.</given-names>
</name>
</person-group>
<article-title>Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy</article-title>
<source/>Neurology
          <volume>64</volume>
<year>2005</year>
<fpage>326</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="pmid">15668432</pub-id>
</element-citation>
</ref>
<ref id="bib1155">
<element-citation id="sbref1155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Eldik</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>S100 beta expression in Alzheimer’s disease: relation to neuropathology in brain regions</article-title>
<source/>Biochim. Biophys. Acta
          <volume>1223</volume>
<year>1994</year>
<fpage>398</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="pmid">7918676</pub-id>
</element-citation>
</ref>
<ref id="bib1160">
<element-citation id="sbref1160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olabarria</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Noristani</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Astrocytes in Alzheimer’s disease</article-title>
<source/>Neurotherapeutics
          <volume>7</volume>
<year>2010</year>
<fpage>399</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="pmid">20880504</pub-id>
</element-citation>
</ref>
<ref id="bib1165">
<element-citation id="sbref1165" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
<name>
<surname>Farrel</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Mischel</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<chapter-title>Diagnostic Neuropathology</chapter-title>
<edition>1st edition</edition>
<year>1998</year>
<publisher-name>CRC Press</publisher-name>
</element-citation>
</ref>
<ref id="bib1170">
<element-citation id="sbref1170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Hippocampal sclerosis: causes and prevention</article-title>
<source/>Semin. Neurol.
          <volume>35</volume>
<year>2015</year>
<fpage>193</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="pmid">26060898</pub-id>
</element-citation>
</ref>
<ref id="bib1175">
<element-citation id="sbref1175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walz</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Role of astrocytes in the clearance of excess extracellular potassium</article-title>
<source/>Neurochem. Int.
          <volume>36</volume>
<year>2000</year>
<fpage>291</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">10732996</pub-id>
</element-citation>
</ref>
<ref id="bib1180">
<element-citation id="sbref1180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webster</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>O’Grady</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kleinman</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Weickert</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia</article-title>
<source/>Neuroscience
          <volume>133</volume>
<year>2005</year>
<fpage>453</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="pmid">15885920</pub-id>
</element-citation>
</ref>
<ref id="bib1185">
<element-citation id="sbref1185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wharton</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>O’Callaghan</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Savva</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>J. a. R.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Brayne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ince</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>MRC Cognitive Function and Ageing Neuropathology Study Group</surname>
</name>
</person-group>
<article-title>Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia</article-title>
<source/>Dement. Geriatr. Cogn. Disord.
          <volume>27</volume>
<year>2009</year>
<fpage>465</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="pmid">19420941</pub-id>
</element-citation>
</ref>
<ref id="bib1190">
<element-citation id="sbref1190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whittle</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sartori</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Dierssen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lubec</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Singewald</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development</article-title>
<source/>Pediatrics
          <volume>120</volume>
<year>2007</year>
<fpage>e1465</fpage>
<lpage>e1471</lpage>
<pub-id pub-id-type="pmid">17998315</pub-id>
</element-citation>
</ref>
<ref id="bib1195">
<element-citation id="sbref1195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wieshmann</surname>
<given-names>U.C.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Symms</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Birnie</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Shorvon</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Water diffusion in the human hippocampus in epilepsy</article-title>
<source/>Magn. Reson. Imaging
          <volume>17</volume>
<year>1999</year>
<fpage>29</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">9888396</pub-id>
</element-citation>
</ref>
<ref id="bib1200">
<element-citation id="sbref1200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilcock</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Vitek</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Colton</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease</article-title>
<source/>Neuroscience
          <volume>159</volume>
<year>2009</year>
<fpage>1055</fpage>
<lpage>1069</lpage>
<pub-id pub-id-type="pmid">19356689</pub-id>
</element-citation>
</ref>
<ref id="bib1205">
<element-citation id="sbref1205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilhelmsson</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Bushong</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Smarr</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Phung</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Terada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ellisman</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Pekny</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>103</volume>
<year>2006</year>
<fpage>17513</fpage>
<lpage>17518</lpage>
<pub-id pub-id-type="pmid">17090684</pub-id>
</element-citation>
</ref>
<ref id="bib1210">
<element-citation id="sbref1210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>C.M.B.</given-names>
</name>
<name>
<surname>Rosenhouse-Dantsker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Matavel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>O-Uchi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McBeath</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Molecular basis of decreased Kir4.1 function in SeSAME/EAST syndrome</article-title>
<source/>J. Am. Soc. Nephrol.
          <volume>21</volume>
<year>2010</year>
<fpage>2117</fpage>
<lpage>2129</lpage>
<pub-id pub-id-type="pmid">21088294</pub-id>
</element-citation>
</ref>
<ref id="bib1215">
<element-citation id="sbref1215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisniewski</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Wegiel</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Spatial relationships between astrocytes and classical plaque components</article-title>
<source/>Neurobiol. Aging
          <volume>12</volume>
<year>1991</year>
<fpage>593</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">1770990</pub-id>
</element-citation>
</ref>
<ref id="bib1220">
<element-citation id="sbref1220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisniewski</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis</article-title>
<source/>Am. J. Med. Genet. Suppl.
          <volume>7</volume>
<year>1990</year>
<fpage>274</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="pmid">2149962</pub-id>
</element-citation>
</ref>
<ref id="bib1225">
<element-citation id="sbref1225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wortmann</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Dementia: a global health priority – highlights from an ADI and World Health Organization report</article-title>
<source/>Alzheimers Res. Ther.
          <volume>4</volume>
<year>2012</year>
<fpage>40</fpage>
<pub-id pub-id-type="pmid">22995353</pub-id>
</element-citation>
</ref>
<ref id="bib1230">
<element-citation id="sbref1230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gearing</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer’s [corrected] disease model</article-title>
<source/>Nat. Commun.
          <volume>5</volume>
<year>2014</year>
<fpage>4159</fpage>
<pub-id pub-id-type="pmid">24923909</pub-id>
</element-citation>
</ref>
<ref id="bib1235">
<element-citation id="sbref1235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sugihara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saido</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Ihara</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques</article-title>
<source/>Acta Neuropathol. (Berl.)
          <volume>95</volume>
<year>1998</year>
<fpage>217</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="pmid">9542585</pub-id>
</element-citation>
</ref>
<ref id="bib1240">
<element-citation id="sbref1240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lieska</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Glick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>G.D.</given-names>
</name>
</person-group>
<article-title>Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>90</volume>
<year>1993</year>
<fpage>8534</fpage>
<lpage>8537</lpage>
<pub-id pub-id-type="pmid">8378327</pub-id>
</element-citation>
</ref>
<ref id="bib1245">
<element-citation id="sbref1245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lieska</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kriho</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>G.D.</given-names>
</name>
</person-group>
<article-title>Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas</article-title>
<source/>Mol. Chem. Neuropathol.
          <volume>21</volume>
<year>1994</year>
<fpage>155</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">7522006</pub-id>
</element-citation>
</ref>
<ref id="bib1250">
<element-citation id="sbref1250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasui</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dunaway</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Lasalle</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L.-W.</given-names>
</name>
<name>
<surname>Maezawa</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>MeCP2 modulates gene expression pathways in astrocytes</article-title>
<source/>Mol. Autism
          <volume>4</volume>
<year>2013</year>
<fpage>3</fpage>
<pub-id pub-id-type="pmid">23351786</pub-id>
</element-citation>
</ref>
<ref id="bib1255">
<element-citation id="sbref1255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>Z.C.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Sontheimer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange</article-title>
<source/>J. Neurosci.
          <volume>19</volume>
<year>1999</year>
<fpage>10767</fpage>
<lpage>10777</lpage>
<pub-id pub-id-type="pmid">10594060</pub-id>
</element-citation>
</ref>
<ref id="bib1260">
<element-citation id="sbref1260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildiz-Yesiloglu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ankerst</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis</article-title>
<source/>Psychiatry Res.
          <volume>147</volume>
<year>2006</year>
<fpage>1</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">16806850</pub-id>
</element-citation>
</ref>
<ref id="bib1265">
<element-citation id="sbref1265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zdaniuk</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wierzba-Bobrowicz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Szpak</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Stępień</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Astroglia disturbances during development of the central nervous system in fetuses with Down’s syndrome</article-title>
<source/>Folia Neuropathol.
          <volume>49</volume>
<year>2011</year>
<fpage>109</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="pmid">21845539</pub-id>
</element-citation>
</ref>
<ref id="bib1270">
<element-citation id="sbref1270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Caneda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Plaza</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>M.S.B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cheshier</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Shuer</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Gephart</surname>
<given-names>M.G.H.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse</article-title>
<source/>Neuron
          <volume>89</volume>
<year>2016</year>
<fpage>37</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">26687838</pub-id>
</element-citation>
</ref>
<ref id="bib1275">
<element-citation id="sbref1275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Gourine</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Rusakov</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Time-resolved imaging reveals heterogeneous landscapes of nanomolar Ca(2+) in neurons and astroglia</article-title>
<source/>Neuron
          <volume>88</volume>
<year>2015</year>
<fpage>277</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="pmid">26494277</pub-id>
</element-citation>
</ref>
</ref-list>
<ack id="ack0005">
<title>Acknowledgements</title>
<p>This work was supported by grants from INSERM, CNRS, College de France and ERC to N.R., from Neuropôle de Recherche Francilien (NeRF) and Ligue Francaise contre l’Epilepsie (LFCE) to E.D., and from Observatoire B2V des memoires to F.V.</p>
</ack>
</back>
</article>
</pmc-articleset>